O95150	TNF15_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tumor necrosis factor ligand superfamily member 15 (TNF ligand-related molecule 1) (Vascular endothelial cell growth inhibitor) [Cleaved into: Tumor necrosis factor ligand superfamily member 15, membrane form; Tumor necrosis factor ligand superfamily member 15, secreted form]	TNFSF15 TL1 VEGI	11931;	9606.ENSP00000363157;
Q9HBW9	AGRL4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adhesion G protein-coupled receptor L4 (EGF, latrophilin and seven transmembrane domain-containing protein 1) (EGF-TM7-latrophilin-related protein) (ETL protein)	ADGRL4 ELTD1 ETL UNQ202/PRO228	20822;	9606.ENSP00000359778;
Q15582	BGH3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3) (Kerato-epithelin) (RGD-containing collagen-associated protein) (RGD-CAP)	TGFBI BIGH3	11771;	9606.ENSP00000416330;
P35869	AHR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Aryl hydrocarbon receptor (Ah receptor) (AhR) (Class E basic helix-loop-helix protein 76) (bHLHe76)	AHR BHLHE76	348;	9606.ENSP00000242057;
P31749	AKT1_HUMAN	reviewed	Evidence at protein level	5 out of 5	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)	AKT1 PKB RAC	391;	9606.ENSP00000451828;
O60241	AGRB2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adhesion G protein-coupled receptor B2 (Brain-specific angiogenesis inhibitor 2)	ADGRB2 BAI2	944;	9606.ENSP00000362759;
P31751	AKT2_HUMAN	reviewed	Evidence at protein level	5 out of 5	RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta)	AKT2	392;	9606.ENSP00000375892;
Q7Z4H4	ADM2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein ADM2 (Intermedin) [Cleaved into: Adrenomedullin-2 (AM2) (Intermedin-long) (IMDL); Intermedin-short (IMDS)]	ADM2 AM2	28898;	9606.ENSP00000379087;
Q9Y2J4	AMOL2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Angiomotin-like protein 2 (Leman coiled-coil protein) (LCCP)	AMOTL2 KIAA0989	17812;	9606.ENSP00000424765;
P05090	APOD_HUMAN	reviewed	Evidence at protein level	5 out of 5	Apolipoprotein D (Apo-D) (ApoD)	APOD	612;	9606.ENSP00000345179;
P49682	CXCR3_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-X-C chemokine receptor type 3 (CXC-R3) (CXCR-3) (CKR-L2) (G protein-coupled receptor 9) (Interferon-inducible protein 10 receptor) (IP-10 receptor) (CD antigen CD183)	CXCR3 GPR9	4540;	9606.ENSP00000362795;
P04626	ERBB2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340)	ERBB2 HER2 MLN19 NEU NGL	3430;	9606.ENSP00000269571;
Q99814	EPAS1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Endothelial PAS domain-containing protein 1 (EPAS-1) (Basic-helix-loop-helix-PAS protein MOP2) (Class E basic helix-loop-helix protein 73) (bHLHe73) (HIF-1-alpha-like factor) (HLF) (Hypoxia-inducible factor 2-alpha) (HIF-2-alpha) (HIF2-alpha) (Member of PAS protein 2) (PAS domain-containing protein 2)	EPAS1 BHLHE73 HIF2A MOP2 PASD2	3374;	9606.ENSP00000263734;
Q6UW88	EPGN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Epigen (Epithelial mitogen) (EPG)	EPGN UNQ3072/PRO9904	17470;	9606.ENSP00000411898;
P21709	EPHA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ephrin type-A receptor 1 (hEpha1) (EC 2.7.10.1) (EPH tyrosine kinase) (EPH tyrosine kinase 1) (Erythropoietin-producing hepatoma receptor) (Tyrosine-protein kinase receptor EPH)	EPHA1 EPH EPHT EPHT1	3385;	9606.ENSP00000275815;
P15291	B4GT1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (Lactose synthase A protein) (EC 2.4.1.22) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1]	B4GALT1 GGTB2	924;	9606.ENSP00000369055;
Q9BWT7	CAR10_HUMAN	reviewed	Evidence at protein level	5 out of 5	Caspase recruitment domain-containing protein 10 (CARD-containing MAGUK protein 3) (Carma 3)	CARD10 CARMA3	16422;	9606.ENSP00000384570;
Q4VCS5	AMOT_HUMAN	reviewed	Evidence at protein level	5 out of 5	Angiomotin	AMOT KIAA1071	17810;	9606.ENSP00000361027;
O00175	CCL24_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C motif chemokine 24 (CK-beta-6) (Eosinophil chemotactic protein 2) (Eotaxin-2) (Myeloid progenitor inhibitory factor 2) (MPIF-2) (Small-inducible cytokine A24)	CCL24 MPIF2 SCYA24	10623;	9606.ENSP00000400533;
Q9Y696	CLIC4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Chloride intracellular channel protein 4 (Intracellular chloride ion channel protein p64H1)	CLIC4	13518;	9606.ENSP00000363500;
Q96BA8	CR3L1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cyclic AMP-responsive element-binding protein 3-like protein 1 (cAMP-responsive element-binding protein 3-like protein 1) (Old astrocyte specifically-induced substance) (OASIS) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 1]	CREB3L1 OASIS PSEC0238	18856;	9606.ENSP00000481956;
Q9UHF1	EGFL7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Epidermal growth factor-like protein 7 (EGF-like protein 7) (Multiple epidermal growth factor-like domains protein 7) (Multiple EGF-like domains protein 7) (NOTCH4-like protein) (Vascular endothelial statin) (VE-statin) (Zneu1)	EGFL7 MEGF7 UNQ187/PRO1449	20594;	9606.ENSP00000360764;
Q99944	EGFL8_HUMAN	reviewed	Evidence at protein level	5 out of 5	Epidermal growth factor-like protein 8 (EGF-like protein 8) (Vascular endothelial statin-2) (VE-statin-2)	EGFL8 C6orf8 NG3 UNQ8752/PRO29920	13944;	9606.ENSP00000378888;
P02750	A2GL_HUMAN	reviewed	Evidence at protein level	5 out of 5	Leucine-rich alpha-2-glycoprotein (LRG)	LRG1 LRG	29480;	9606.ENSP00000302621;
Q9BY76	ANGL4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Angiopoietin-related protein 4 (Angiopoietin-like protein 4) (Hepatic fibrinogen/angiopoietin-related protein) (HFARP) [Cleaved into: ANGPTL4 N-terminal chain; ANGPTL4 C-terminal chain]	ANGPTL4 ARP4 HFARP PGAR PP1158 PSEC0166 UNQ171/PRO197	16039;	9606.ENSP00000301455;
P02749	APOH_HUMAN	reviewed	Evidence at protein level	5 out of 5	Beta-2-glycoprotein 1 (APC inhibitor) (Activated protein C-binding protein) (Anticardiolipin cofactor) (Apolipoprotein H) (Apo-H) (Beta-2-glycoprotein I) (B2GPI) (Beta(2)GPI)	APOH B2G1	616;	9606.ENSP00000205948;
Q9H6X2	ANTR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Anthrax toxin receptor 1 (Tumor endothelial marker 8)	ANTXR1 ATR TEM8	21014;	9606.ENSP00000301945;
Q6UVK1	CSPG4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Chondroitin sulfate proteoglycan 4 (Chondroitin sulfate proteoglycan NG2) (Melanoma chondroitin sulfate proteoglycan) (Melanoma-associated chondroitin sulfate proteoglycan)	CSPG4 MCSP	2466;	9606.ENSP00000312506;
Q01955	CO4A3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Collagen alpha-3(IV) chain (Goodpasture antigen) [Cleaved into: Tumstatin]	COL4A3	2204;	9606.ENSP00000379823;
Q9NZJ5	E2AK3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Eukaryotic translation initiation factor 2-alpha kinase 3 (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase) (HsPEK)	EIF2AK3 PEK PERK	3255;	9606.ENSP00000307235;
P12821	ACE_HUMAN	reviewed	Evidence at protein level	5 out of 5	Angiotensin-converting enzyme (ACE) (EC 3.2.1.-) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form]	ACE DCP DCP1	2707;	9606.ENSP00000290866;
Q13685	AAMP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Angio-associated migratory cell protein	AAMP	18;	9606.ENSP00000248450;
O94812	BAIP3_HUMAN	reviewed	Evidence at protein level	5 out of 5	BAI1-associated protein 3 (BAP3) (Brain-specific angiogenesis inhibitor I-associated protein 3)	BAIAP3 KIAA0734	948;	9606.ENSP00000324510;
Q96PE1	AGRA2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adhesion G protein-coupled receptor A2 (G-protein coupled receptor 124) (Tumor endothelial marker 5)	ADGRA2 GPR124 KIAA1531 TEM5	17849;	9606.ENSP00000406367;
O14514	AGRB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-40 (Vstat40); Vasculostatin-120 (Vstat120)]	ADGRB1 BAI1	943;	9606.ENSP00000430945;
O60242	AGRB3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adhesion G protein-coupled receptor B3 (Brain-specific angiogenesis inhibitor 3)	ADGRB3 BAI3 KIAA0550	945;	9606.ENSP00000359630;
Q96BT7	ALKB8_HUMAN	reviewed	Evidence at protein level	5 out of 5	Alkylated DNA repair protein alkB homolog 8 (Probable alpha-ketoglutarate-dependent dioxygenase ABH8) (S-adenosyl-L-methionine-dependent tRNA methyltransferase ABH8) (tRNA (carboxymethyluridine(34)-5-O)-methyltransferase ABH8) (EC 2.1.1.229)	ALKBH8 ABH8	25189;	9606.ENSP00000397673;
O14672	ADA10_HUMAN	reviewed	Evidence at protein level	5 out of 5	Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (CDw156) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c)	ADAM10 KUZ MADM	188;	9606.ENSP00000260408;
Q13444	ADA15_HUMAN	reviewed	Evidence at protein level	5 out of 5	Disintegrin and metalloproteinase domain-containing protein 15 (ADAM 15) (EC 3.4.24.-) (Metalloprotease RGD disintegrin protein) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 15) (MDC-15) (Metargidin)	ADAM15 MDC15	193;	9606.ENSP00000349436;
Q15848	ADIPO_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adiponectin (30 kDa adipocyte complement-related protein) (Adipocyte complement-related 30 kDa protein) (ACRP30) (Adipocyte, C1q and collagen domain-containing protein) (Adipose most abundant gene transcript 1 protein) (apM-1) (Gelatin-binding protein)	ADIPOQ ACDC ACRP30 APM1 GBP28	13633;	9606.ENSP00000389814;
O95971	BY55_HUMAN	reviewed	Evidence at protein level	5 out of 5	CD160 antigen (Natural killer cell receptor BY55) (CD antigen CD160) [Cleaved into: CD160 antigen, soluble form]	CD160 BY55	17013;	9606.ENSP00000235933;
Q00535	CDK5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cyclin-dependent kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Cyclin-dependent-like kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit)	CDK5 CDKN5 PSSALRE	1774;	9606.ENSP00000419782;
P51813	BMX_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein) (Epithelial and endothelial tyrosine kinase) (ETK) (NTK38)	BMX	1079;	9606.ENSP00000350224;
P30556	AGTR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Type-1 angiotensin II receptor (AT1AR) (AT1BR) (Angiotensin II type-1 receptor) (AT1)	AGTR1 AGTR1A AGTR1B AT2R1 AT2R1B	336;	9606.ENSP00000419422;
P63261	ACTG_HUMAN	reviewed	Evidence at protein level	5 out of 5	Actin, cytoplasmic 2 (Gamma-actin) [Cleaved into: Actin, cytoplasmic 2, N-terminally processed]	ACTG1 ACTG	144;	9606.ENSP00000458162;
Q12904	AIMP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 (Multisynthase complex auxiliary component p43) [Cleaved into: Endothelial monocyte-activating polypeptide 2 (EMAP-2) (Endothelial monocyte-activating polypeptide II) (EMAP-II) (Small inducible cytokine subfamily E member 1)]	AIMP1 EMAP2 SCYE1	10648;	9606.ENSP00000378191;
O00622	CCN1_HUMAN	reviewed	Evidence at protein level	5 out of 5	CCN family member 1 (Cellular communication network factor 1) (Cysteine-rich angiogenic inducer 61) (Insulin-like growth factor-binding protein 10) (IBP-10) (IGF-binding protein 10) (IGFBP-10) (Protein CYR61) (Protein GIG1)	CCN1 CYR61 GIG1 IGFBP10	2654;	9606.ENSP00000398736;
Q9HCU0	CD248_HUMAN	reviewed	Evidence at protein level	5 out of 5	Endosialin (Tumor endothelial marker 1) (CD antigen CD248)	CD248 CD164L1 TEM1	18219;	9606.ENSP00000308117;
P07203	GPX1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Glutathione peroxidase 1 (GPx-1) (GSHPx-1) (EC 1.11.1.9) (Cellular glutathione peroxidase)	GPX1	4553;	9606.ENSP00000407375;
P28799	GRN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Progranulin (PGRN) (Acrogranin) (Epithelin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (Granulin precursor) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)]	GRN	4601;	9606.ENSP00000053867;
Q14956	GPNMB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transmembrane glycoprotein NMB (Hematopoietic growth factor inducible neurokinin-1 type)	GPNMB HGFIN NMB UNQ1725/PRO9925	4462;	9606.ENSP00000371420;
P10767	FGF6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Fibroblast growth factor 6 (FGF-6) (Heparin secretory-transforming protein 2) (HST-2) (HSTF-2) (Heparin-binding growth factor 6) (HBGF-6)	FGF6 HST2 HSTF2	3684;	9606.ENSP00000228837;
P31371	FGF9_HUMAN	reviewed	Evidence at protein level	5 out of 5	Fibroblast growth factor 9 (FGF-9) (Glia-activating factor) (GAF) (Heparin-binding growth factor 9) (HBGF-9)	FGF9	3687;	9606.ENSP00000371790;
Q14512	FGFP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Fibroblast growth factor-binding protein 1 (FGF-BP) (FGF-BP1) (FGF-binding protein 1) (FGFBP-1) (17 kDa heparin-binding growth factor-binding protein) (17 kDa HBGF-binding protein) (HBp17)	FGFBP1 FGFBP HBP17	19695;	9606.ENSP00000371770;
Q9Y3L3	3BP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	SH3 domain-binding protein 1	SH3BP1	10824;	9606.ENSP00000350018;
Q9UL18	AGO1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein argonaute-1 (Argonaute1) (hAgo1) (Argonaute RISC catalytic component 1) (Eukaryotic translation initiation factor 2C 1) (eIF-2C 1) (eIF2C 1) (Putative RNA-binding protein Q99)	AGO1 EIF2C1	3262;	9606.ENSP00000362300;
P62736	ACTA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Actin, aortic smooth muscle (Alpha-actin-2) (Cell growth-inhibiting gene 46 protein) [Cleaved into: Actin, aortic smooth muscle, intermediate form]	ACTA2 ACTSA ACTVS GIG46	130;	9606.ENSP00000402373;
Q96IZ2	ADTRP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Androgen-dependent TFPI-regulating protein (Fatty acid esters of hydroxy fatty acids hydrolase ADTRP) (FAHFA hydrolase ADTRP) (EC 3.1.-.-)	ADTRP C6orf105	21214;	9606.ENSP00000229583;
Q9NR80	ARHG4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Rho guanine nucleotide exchange factor 4 (APC-stimulated guanine nucleotide exchange factor 1) (Asef) (Asef1)	ARHGEF4 KIAA1112	684;	9606.ENSP00000316845;
O15123	ANGP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Angiopoietin-2 (ANG-2)	ANGPT2	485;	9606.ENSP00000314897;
P29972	AQP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule)	AQP1 CHIP28	633;	9606.ENSP00000311165;
P12429	ANXA3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Annexin A3 (35-alpha calcimedin) (Annexin III) (Annexin-3) (Inositol 1,2-cyclic phosphate 2-phosphohydrolase) (Lipocortin III) (Placental anticoagulant protein III) (PAP-III)	ANXA3 ANX3	541;	9606.ENSP00000264908;
P08572	CO4A2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Collagen alpha-2(IV) chain [Cleaved into: Canstatin]	COL4A2	2203;	9606.ENSP00000353654;
P01024	CO3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Complement C3 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1) [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc); Complement C3 alpha chain; C3a anaphylatoxin; Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2]	C3 CPAMD1	1318;	9606.ENSP00000245907;
Q9NR61	DLL4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Delta-like protein 4 (Drosophila Delta homolog 4) (Delta4)	DLL4 UNQ1895/PRO4341	2910;	9606.ENSP00000249749;
P37023	ACVL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serine/threonine-protein kinase receptor R3 (SKR3) (EC 2.7.11.30) (Activin receptor-like kinase 1) (ALK-1) (TGF-B superfamily receptor type I) (TSR-I)	ACVRL1 ACVRLK1 ALK1	175;	9606.ENSP00000373574;
O43184	ADA12_HUMAN	reviewed	Evidence at protein level	5 out of 5	Disintegrin and metalloproteinase domain-containing protein 12 (ADAM 12) (EC 3.4.24.-) (Meltrin-alpha)	ADAM12 MLTN UNQ346/PRO545	190;	9606.ENSP00000357668;
Q8IY63	AMOL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Angiomotin-like protein 1	AMOTL1	17811;	9606.ENSP00000387739;
Q8N302	AGGF1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Angiogenic factor with G patch and FHA domains 1 (Angiogenic factor VG5Q) (hVG5Q) (G patch domain-containing protein 7) (Vasculogenesis gene on 5q protein)	AGGF1 GPATC7 GPATCH7 VG5Q	24684;	9606.ENSP00000316109;
P15336	ATF2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cyclic AMP-dependent transcription factor ATF-2 (cAMP-dependent transcription factor ATF-2) (Activating transcription factor 2) (Cyclic AMP-responsive element-binding protein 2) (CREB-2) (cAMP-responsive element-binding protein 2) (HB16) (cAMP response element-binding protein CRE-BP1)	ATF2 CREB2 CREBP1	784;	9606.ENSP00000264110;
P49238	CX3C1_HUMAN	reviewed	Evidence at protein level	5 out of 5	CX3C chemokine receptor 1 (C-X3-C CKR-1) (CX3CR1) (Beta chemokine receptor-like 1) (CMK-BRL-1) (CMK-BRL1) (Fractalkine receptor) (G-protein coupled receptor 13) (V28)	CX3CR1 CMKBRL1 GPR13	2558;	9606.ENSP00000351059;
Q9Y2X7	GIT1_HUMAN	reviewed	Evidence at protein level	5 out of 5	ARF GTPase-activating protein GIT1 (ARF GAP GIT1) (Cool-associated and tyrosine-phosphorylated protein 1) (CAT-1) (CAT1) (G protein-coupled receptor kinase-interactor 1) (GRK-interacting protein 1) (p95-APP1)	GIT1	4272;	9606.ENSP00000378338;
P20800	EDN2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Endothelin-2 (ET-2) (Preproendothelin-2) (PPET2)	EDN2	3177;	9606.ENSP00000361668;
Q9Y5C1	ANGL3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Angiopoietin-related protein 3 (Angiopoietin-5) (ANG-5) (Angiopoietin-like protein 3) [Cleaved into: ANGPTL3(17-221); ANGPTL3(17-224)]	ANGPTL3 ANGPT5 UNQ153/PRO179	491;	9606.ENSP00000360170;
Q15389	ANGP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Angiopoietin-1 (ANG-1)	ANGPT1 KIAA0003	484;	9606.ENSP00000428340;
P15144	AMPN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Aminopeptidase N (AP-N) (hAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (Myeloid plasma membrane glycoprotein CD13) (gp150) (CD antigen CD13)	ANPEP APN CD13 PEPN	500;	9606.ENSP00000300060;
P07355	ANXA2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Annexin A2 (Annexin II) (Annexin-2) (Calpactin I heavy chain) (Calpactin-1 heavy chain) (Chromobindin-8) (Lipocortin II) (Placental anticoagulant protein IV) (PAP-IV) (Protein I) (p36)	ANXA2 ANX2 ANX2L4 CAL1H LPC2D	537;	9606.ENSP00000346032;
Q9BSQ5	CCM2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cerebral cavernous malformations 2 protein (Malcavernin)	CCM2 C7orf22 PP10187	21708;	9606.ENSP00000370503;
P02647	APOA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Apolipoprotein A-I (Apo-AI) (ApoA-I) (Apolipoprotein A1) [Cleaved into: Proapolipoprotein A-I (ProapoA-I); Truncated apolipoprotein A-I (Apolipoprotein A-I(1-242))]	APOA1	600;	9606.ENSP00000236850;
P78325	ADAM8_HUMAN	reviewed	Evidence at protein level	5 out of 5	Disintegrin and metalloproteinase domain-containing protein 8 (ADAM 8) (EC 3.4.24.-) (Cell surface antigen MS2) (CD antigen CD156a)	ADAM8 MS2	215;	9606.ENSP00000453302;
P16066	ANPRA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A)	NPR1 ANPRA	7943;	9606.ENSP00000357669;
P55290	CAD13_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cadherin-13 (Heart cadherin) (H-cadherin) (P105) (Truncated cadherin) (T-cad) (T-cadherin)	CDH13 CDHH	1753;	9606.ENSP00000268613;
P21730	C5AR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	C5a anaphylatoxin chemotactic receptor 1 (C5a anaphylatoxin chemotactic receptor) (C5a-R) (C5aR) (CD antigen CD88)	C5AR1 C5AR C5R1	1338;	9606.ENSP00000347197;
Q9H6U6	BCAS3_HUMAN	reviewed	Evidence at protein level	5 out of 5	BCAS3 microtubule associated cell migration factor (Breast carcinoma-amplified sequence 3) (GAOB1)	BCAS3	14347;	9606.ENSP00000375067;
P12644	BMP4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Bone morphogenetic protein 4 (BMP-4) (Bone morphogenetic protein 2B) (BMP-2B)	BMP4 BMP2B DVR4	1071;	9606.ENSP00000245451;
Q03135	CAV1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Caveolin-1	CAV1 CAV	1527;	9606.ENSP00000339191;
Q16581	C3AR_HUMAN	reviewed	Evidence at protein level	5 out of 5	C3a anaphylatoxin chemotactic receptor (C3AR) (C3a-R)	C3AR1 AZ3B C3R1 HNFAG09	1319;	9606.ENSP00000302079;
P33151	CADH5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cadherin-5 (7B4 antigen) (Vascular endothelial cadherin) (VE-cadherin) (CD antigen CD144)	CDH5	1764;	9606.ENSP00000344115;
P80162	CXCL6_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-X-C motif chemokine 6 (Chemokine alpha 3) (CKA-3) (Granulocyte chemotactic protein 2) (GCP-2) (Small-inducible cytokine B6) [Cleaved into: Small-inducible cytokine B6, N-processed variant 1; Small-inducible cytokine B6, N-processed variant 2; Small-inducible cytokine B6, N-processed variant 3]	CXCL6 GCP2 SCYB6	10643;	9606.ENSP00000226317;
Q96GG9	DCNL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	DCN1-like protein 1 (DCNL1) (DCUN1 domain-containing protein 1) (Defective in cullin neddylation protein 1-like protein 1) (Squamous cell carcinoma-related oncogene)	DCUN1D1 DCN1 DCUN1L1 RP42 SCCRO	18184;	9606.ENSP00000292782;
O14641	DVL2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Segment polarity protein dishevelled homolog DVL-2 (Dishevelled-2) (DSH homolog 2)	DVL2	3086;	9606.ENSP00000005340;
Q9H6Z9	EGLN3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prolyl hydroxylase EGLN3 (EC 1.14.11.-) (Egl nine homolog 3) (EC 1.14.11.29) (HPH-1) (Hypoxia-inducible factor prolyl hydroxylase 3) (HIF-PH3) (HIF-prolyl hydroxylase 3) (HPH-3) (Prolyl hydroxylase domain-containing protein 3) (PHD3)	EGLN3	14661;	9606.ENSP00000250457;
P17813	EGLN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Endoglin (CD antigen CD105)	ENG END	3349;	9606.ENSP00000362299;
P23634	AT2B4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4)	ATP2B4 ATP2B2 MXRA1	817;	9606.ENSP00000350310;
P06576	ATPB_HUMAN	reviewed	Evidence at protein level	5 out of 5	ATP synthase subunit beta, mitochondrial (EC 7.1.2.2) (ATP synthase F1 subunit beta)	ATP5F1B ATP5B ATPMB ATPSB	830;	9606.ENSP00000262030;
P25705	ATPA_HUMAN	reviewed	Evidence at protein level	5 out of 5	ATP synthase subunit alpha, mitochondrial (ATP synthase F1 subunit alpha)	ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM	823;	9606.ENSP00000381736;
P36544	ACHA7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Neuronal acetylcholine receptor subunit alpha-7	CHRNA7 NACHRA7	1960;	9606.ENSP00000407546;
Q9UKV8	AGO2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein argonaute-2 (Argonaute2) (hAgo2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (PAZ Piwi domain protein) (PPD) (Protein slicer)	AGO2 EIF2C2	3263;	9606.ENSP00000220592;
Q9Y243	AKT3_HUMAN	reviewed	Evidence at protein level	5 out of 5	RAC-gamma serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-3) (Protein kinase B gamma) (PKB gamma) (RAC-PK-gamma) (STK-2)	AKT3 PKBG	393;	9606.ENSP00000263826;
P35318	ADML_HUMAN	reviewed	Evidence at protein level	5 out of 5	Pro-adrenomedullin [Cleaved into: Adrenomedullin (AM); Proadrenomedullin N-20 terminal peptide (ProAM N-terminal 20 peptide) (PAMP) (ProAM-N20)]	ADM AM	259;	9606.ENSP00000436607;
Q08289	CACB2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Voltage-dependent L-type calcium channel subunit beta-2 (CAB2) (Calcium channel voltage-dependent subunit beta 2) (Lambert-Eaton myasthenic syndrome antigen B) (MYSB)	CACNB2 CACNLB2 MYSB	1402;	9606.ENSP00000320025;
P01019	ANGT_HUMAN	reviewed	Evidence at protein level	5 out of 5	Angiotensinogen (Serpin A8) [Cleaved into: Angiotensin-1 (Angiotensin 1-10) (Angiotensin I) (Ang I); Angiotensin-2 (Angiotensin 1-8) (Angiotensin II) (Ang II); Angiotensin-3 (Angiotensin 2-8) (Angiotensin III) (Ang III) (Des-Asp[1]-angiotensin II); Angiotensin-4 (Angiotensin 3-8) (Angiotensin IV) (Ang IV); Angiotensin 1-9; Angiotensin 1-7; Angiotensin 1-5; Angiotensin 1-4]	AGT SERPINA8	333;	9606.ENSP00000355627;
P34972	CNR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)	CNR2 CB2A CB2B	2160;	9606.ENSP00000363596;
P02462	CO4A1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Collagen alpha-1(IV) chain [Cleaved into: Arresten]	COL4A1	2202;	9606.ENSP00000364979;
P50281	MMP14_HUMAN	reviewed	Evidence at protein level	5 out of 5	Matrix metalloproteinase-14 (MMP-14) (EC 3.4.24.80) (MMP-X1) (Membrane-type matrix metalloproteinase 1) (MT-MMP 1) (MTMMP1) (Membrane-type-1 matrix metalloproteinase) (MT1-MMP) (MT1MMP)	MMP14	7160;	9606.ENSP00000308208;
P08253	MMP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	72 kDa type IV collagenase (EC 3.4.24.24) (72 kDa gelatinase) (Gelatinase A) (Matrix metalloproteinase-2) (MMP-2) (TBE-1) [Cleaved into: PEX]	MMP2 CLG4A	7166;	9606.ENSP00000219070;
P04049	RAF1_HUMAN	reviewed	Evidence at protein level	5 out of 5	RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1)	RAF1 RAF	9829;	9606.ENSP00000251849;
P51153	RAB13_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ras-related protein Rab-13 (Cell growth-inhibiting gene 4 protein)	RAB13 GIG4	9762;	9606.ENSP00000357564;
Q5U651	RAIN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ras-interacting protein 1 (Rain)	RASIP1	24716;	9606.ENSP00000222145;
O60894	RAMP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Receptor activity-modifying protein 1 (Calcitonin-receptor-like receptor activity-modifying protein 1) (CRLR activity-modifying protein 1)	RAMP1	9843;	9606.ENSP00000254661;
O60895	RAMP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Receptor activity-modifying protein 2 (Calcitonin-receptor-like receptor activity-modifying protein 2) (CRLR activity-modifying protein 2)	RAMP2	9844;	9606.ENSP00000253796;
P98160	PGBM_HUMAN	reviewed	Evidence at protein level	5 out of 5	Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide]	HSPG2	5273;	9606.ENSP00000363827;
Q99969	RARR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Retinoic acid receptor responder protein 2 (Chemerin) (RAR-responsive protein TIG2) (Tazarotene-induced gene 2 protein)	RARRES2 TIG2	9868;	9606.ENSP00000418009;
P04090	REL2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prorelaxin H2 [Cleaved into: Relaxin B chain; Relaxin A chain]	RLN2	10027;	9606.ENSP00000371040;
O95980	RECK_HUMAN	reviewed	Evidence at protein level	5 out of 5	Reversion-inducing cysteine-rich protein with Kazal motifs (hRECK) (Suppressor of tumorigenicity 15 protein)	RECK ST15	11345;	9606.ENSP00000367202;
Q9UHI8	ATS1_HUMAN	reviewed	Evidence at protein level	5 out of 5	A disintegrin and metalloproteinase with thrombospondin motifs 1 (ADAM-TS 1) (ADAM-TS1) (ADAMTS-1) (EC 3.4.24.-) (METH-1)	ADAMTS1 KIAA1346 METH1	217;	9606.ENSP00000284984;
P0DMC3	ELA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Apelin receptor early endogenous ligand (Protein Elabela) (ELA) (Protein Toddler)	APELA ELA TDL	48925;	9606.ENSP00000484618;
P20702	ITAX_HUMAN	reviewed	Evidence at protein level	5 out of 5	Integrin alpha-X (CD11 antigen-like family member C) (Leu M5) (Leukocyte adhesion glycoprotein p150,95 alpha chain) (Leukocyte adhesion receptor p150,95) (CD antigen CD11c)	ITGAX CD11C	6152;	9606.ENSP00000454623;
P23458	JAK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tyrosine-protein kinase JAK1 (EC 2.7.10.2) (Janus kinase 1) (JAK-1)	JAK1 JAK1A JAK1B	6190;	9606.ENSP00000343204;
P05556	ITB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD antigen CD29)	ITGB1 FNRB MDF2 MSK12	6153;	9606.ENSP00000379350;
Q9UK05	GDF2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Growth/differentiation factor 2 (GDF-2) (Bone morphogenetic protein 9) (BMP-9)	GDF2 BMP9	4217;	9606.ENSP00000463051;
Q96TA1	NIBA2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein Niban 2 (Meg-3) (Melanoma invasion by ERK) (MINERVA) (Niban-like protein 1) (Protein FAM129B)	NIBAN2 C9orf88 FAM129B	25282;	9606.ENSP00000362409;
Q96PH1	NOX5_HUMAN	reviewed	Evidence at protein level	5 out of 5	NADPH oxidase 5 (EC 1.6.3.-)	NOX5	14874;	9606.ENSP00000373518;
Q9UJU2	LEF1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lymphoid enhancer-binding factor 1 (LEF-1) (T cell-specific transcription factor 1-alpha) (TCF1-alpha)	LEF1	6551;	9606.ENSP00000265165;
O00470	MEIS1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Homeobox protein Meis1	MEIS1	7000;	9606.ENSP00000272369;
P22736	NR4A1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nuclear receptor subfamily 4 group A member 1 (Early response protein NAK1) (Nuclear hormone receptor NUR/77) (Nur77) (Orphan nuclear receptor HMR) (Orphan nuclear receptor TR3) (ST-59) (Testicular receptor 3)	NR4A1 GFRP1 HMR NAK1	7980;	9606.ENSP00000440864;
Q9NRA1	PDGFC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Platelet-derived growth factor C (PDGF-C) (Fallotein) (Spinal cord-derived growth factor) (SCDGF) (VEGF-E) [Cleaved into: Platelet-derived growth factor C, latent form (PDGFC latent form); Platelet-derived growth factor C, receptor-binding form (PDGFC receptor-binding form)]	PDGFC SCDGF UNQ174/PRO200	8801;	9606.ENSP00000422464;
O43827	ANGL7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Angiopoietin-related protein 7 (Angiopoietin-like factor) (Angiopoietin-like protein 7) (Cornea-derived transcript 6 protein)	ANGPTL7 CDT6 UNQ313/PRO356	24078;	9606.ENSP00000366015;
P35414	APJ_HUMAN	reviewed	Evidence at protein level	5 out of 5	Apelin receptor (Angiotensin receptor-like 1) (G-protein coupled receptor APJ) (G-protein coupled receptor HG11)	APLNR AGTRL1 APJ	339;	9606.ENSP00000475344;
P04083	ANXA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Annexin A1 (Annexin I) (Annexin-1) (Calpactin II) (Calpactin-2) (Chromobindin-9) (Lipocortin I) (Phospholipase A2 inhibitory protein) (p35) [Cleaved into: Annexin Ac2-26]	ANXA1 ANX1 LPC1	533;	9606.ENSP00000366109;
P17693	HLAG_HUMAN	reviewed	Evidence at protein level	5 out of 5	HLA class I histocompatibility antigen, alpha chain G (HLA G antigen) (MHC class I antigen G) [Cleaved into: Soluble HLA class I histocompatibility antigen, alpha chain G (sHLA-G)]	HLA-G HLA-6.0 HLAG	4964;	9606.ENSP00000412927;
Q9Y5S8	NOX1_HUMAN	reviewed	Evidence at protein level	5 out of 5	NADPH oxidase 1 (NOX-1) (EC 1.-.-.-) (Mitogenic oxidase 1) (MOX-1) (NADH/NADPH mitogenic oxidase subunit P65-MOX) (NOH-1)	NOX1 MOX1 NOH1	7889;	9606.ENSP00000362057;
Q5VWQ8	DAB2P_HUMAN	reviewed	Evidence at protein level	5 out of 5	Disabled homolog 2-interacting protein (DAB2 interaction protein) (DAB2-interacting protein) (ASK-interacting protein 1) (AIP-1) (DOC-2/DAB-2 interactive protein)	DAB2IP AF9Q34 AIP1 KIAA1743	17294;	9606.ENSP00000259371;
P54762	EPHB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ephrin type-B receptor 1 (EC 2.7.10.1) (ELK) (EPH tyrosine kinase 2) (EPH-like kinase 6) (EK6) (hEK6) (Neuronally-expressed EPH-related tyrosine kinase) (NET) (Tyrosine-protein kinase receptor EPH-2)	EPHB1 ELK EPHT2 HEK6 NET	3392;	9606.ENSP00000381097;
P21802	FGFR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332)	FGFR2 BEK KGFR KSAM	3689;	9606.ENSP00000410294;
Q13164	MK07_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mitogen-activated protein kinase 7 (MAP kinase 7) (MAPK 7) (EC 2.7.11.24) (Big MAP kinase 1) (BMK-1) (Extracellular signal-regulated kinase 5) (ERK-5)	MAPK7 BMK1 ERK5 PRKM7	6880;	9606.ENSP00000311005;
Q04721	NOTC2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)]	NOTCH2	7882;	9606.ENSP00000256646;
P35222	CTNB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Catenin beta-1 (Beta-catenin)	CTNNB1 CTNNB OK/SW-cl.35 PRO2286	2514;	9606.ENSP00000344456;
P01583	IL1A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-1 alpha (IL-1 alpha) (Hematopoietin-1)	IL1A IL1F1	5991;	9606.ENSP00000263339;
P01584	IL1B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-1 beta (IL-1 beta) (Catabolin)	IL1B IL1F2	5992;	9606.ENSP00000263341;
P41134	ID1_HUMAN	reviewed	Evidence at protein level	5 out of 5	DNA-binding protein inhibitor ID-1 (Class B basic helix-loop-helix protein 24) (bHLHb24) (Inhibitor of DNA binding 1) (Inhibitor of differentiation 1)	ID1 BHLHB24 ID	5360;	9606.ENSP00000365280;
P04629	NTRK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (TRK1-transforming tyrosine kinase protein) (Tropomyosin-related kinase A) (Tyrosine kinase receptor) (Tyrosine kinase receptor A) (Trk-A) (gp140trk) (p140-TrkA)	NTRK1 MTC TRK TRKA	8031;	9606.ENSP00000431418;
P58400	NRX1B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Neurexin-1-beta (Neurexin I-beta)	NRXN1	8008;	
P23467	PTPRB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Receptor-type tyrosine-protein phosphatase beta (Protein-tyrosine phosphatase beta) (R-PTP-beta) (EC 3.1.3.48) (Vascular endothelial protein tyrosine phosphatase) (VE-PTP)	PTPRB PTPB	9665;	9606.ENSP00000334928;
O43474	KLF4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Krueppel-like factor 4 (Epithelial zinc finger protein EZF) (Gut-enriched krueppel-like factor)	KLF4 EZF GKLF	6348;	9606.ENSP00000363804;
Q6NYC1	JMJD6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 (EC 1.14.11.-) (Histone arginine demethylase JMJD6) (JmjC domain-containing protein 6) (Jumonji domain-containing protein 6) (Lysyl-hydroxylase JMJD6) (Peptide-lysine 5-dioxygenase JMJD6) (Phosphatidylserine receptor) (Protein PTDSR)	JMJD6 KIAA0585 PSR PTDSR	19355;	9606.ENSP00000394085;
Q15139	KPCD1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu)	PRKD1 PKD PKD1 PRKCM	9407;	9606.ENSP00000333568;
Q8NCW5	NNRE_HUMAN	reviewed	Evidence at protein level	5 out of 5	NAD(P)H-hydrate epimerase (EC 5.1.99.6) (Apolipoprotein A-I-binding protein) (AI-BP) (NAD(P)HX epimerase) (YjeF N-terminal domain-containing protein 1) (YjeF_N1)	NAXE AIBP APOA1BP YJEFN1	18453;	9606.ENSP00000357218;
P46531	NOTC1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	NOTCH1 TAN1	7881;	9606.ENSP00000277541;
Q9H2X6	HIPK2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Homeodomain-interacting protein kinase 2 (hHIPk2) (EC 2.7.11.1)	HIPK2	14402;	9606.ENSP00000385571;
P04196	HRG_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histidine-rich glycoprotein (Histidine-proline-rich glycoprotein) (HPRG)	HRG	5181;	9606.ENSP00000232003;
O14558	HSPB6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Heat shock protein beta-6 (HspB6) (Heat shock 20 kDa-like protein p20)	HSPB6	26511;	9606.ENSP00000468057;
P53582	MAP11_HUMAN	reviewed	Evidence at protein level	5 out of 5	Methionine aminopeptidase 1 (MAP 1) (MetAP 1) (EC 3.4.11.18) (Peptidase M 1)	METAP1 KIAA0094	15789;	9606.ENSP00000296411;
Q9ULC4	MCTS1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)	MCTS1 MCT1	23357;	9606.ENSP00000360365;
P50579	MAP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M)	METAP2 MNPEP P67EIF2	16672;	9606.ENSP00000325312;
Q96QZ7	MAGI1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 (Atrophin-1-interacting protein 3) (AIP-3) (BAI1-associated protein 1) (BAP-1) (Membrane-associated guanylate kinase inverted 1) (MAGI-1) (Trinucleotide repeat-containing gene 19 protein) (WW domain-containing protein 3) (WWP3)	MAGI1 AIP3 BAIAP1 BAP1 TNRC19	946;	9606.ENSP00000385450;
Q9BUP3	HTAI2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Oxidoreductase HTATIP2 (EC 1.1.1.-) (30 kDa HIV-1 TAT-interacting protein) (HIV-1 TAT-interactive protein 2)	HTATIP2 CC3 TIP30	16637;	9606.ENSP00000392985;
P54760	EPHB4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ephrin type-B receptor 4 (EC 2.7.10.1) (Hepatoma transmembrane kinase) (Tyrosine-protein kinase TYRO11)	EPHB4 HTK MYK1 TYRO11	3395;	9606.ENSP00000350896;
Q9P035	HACD3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 3) (HACD3) (Butyrate-induced protein 1) (B-ind1) (hB-ind1) (Protein-tyrosine phosphatase-like A domain-containing protein 1)	HACD3 BIND1 PTPLAD1	24175;	9606.ENSP00000261875;
O60565	GREM1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Gremlin-1 (Cell proliferation-inducing gene 2 protein) (Cysteine knot superfamily 1, BMP antagonist 1) (DAN domain family member 2) (Down-regulated in Mos-transformed cells protein) (Increased in high glucose protein 2) (IHG-2)	GREM1 CKTSF1B1 DAND2 DRM PIG2	2001;	9606.ENSP00000478319;
P22301	IL10_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-10 (IL-10) (Cytokine synthesis inhibitory factor) (CSIF)	IL10	5962;	9606.ENSP00000412237;
O43365	HXA3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Homeobox protein Hox-A3 (Homeobox protein Hox-1E)	HOXA3 HOX1E	5104;	9606.ENSP00000484411;
Q08431	MFGM_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lactadherin (Breast epithelial antigen BA46) (HMFG) (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) [Cleaved into: Lactadherin short form; Medin]	MFGE8	7036;	9606.ENSP00000268150;
Q09328	MGT5A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase V) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)]	MGAT5 GGNT5	7049;	9606.ENSP00000386377;
Q92823	NRCAM_HUMAN	reviewed	Evidence at protein level	5 out of 5	Neuronal cell adhesion molecule (Nr-CAM) (Neuronal surface protein Bravo) (hBravo) (NgCAM-related cell adhesion molecule) (Ng-CAM-related)	NRCAM KIAA0343	7994;	9606.ENSP00000368314;
Q9P0G3	KLK14_HUMAN	reviewed	Evidence at protein level	5 out of 5	Kallikrein-14 (hK14) (EC 3.4.21.-) (Kallikrein-like protein 6) (KLK-L6)	KLK14 KLKL6	6362;	9606.ENSP00000375678;
O95528	GTR10_HUMAN	reviewed	Evidence at protein level	5 out of 5	Solute carrier family 2, facilitated glucose transporter member 10 (Glucose transporter type 10) (GLUT-10)	SLC2A10 GLUT10	13444;	9606.ENSP00000352216;
Q86Z02	HIPK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Homeodomain-interacting protein kinase 1 (EC 2.7.11.1) (Nuclear body-associated kinase 2)	HIPK1 KIAA0630 MYAK NBAK2	19006;	9606.ENSP00000358571;
Q03014	HHEX_HUMAN	reviewed	Evidence at protein level	5 out of 5	Hematopoietically-expressed homeobox protein HHEX (Homeobox protein HEX) (Homeobox protein PRH)	HHEX HEX PRH PRHX	4901;	9606.ENSP00000282728;
Q9NQ38	ISK5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serine protease inhibitor Kazal-type 5 (Lympho-epithelial Kazal-type-related inhibitor) (LEKTI) [Cleaved into: Hemofiltrate peptide HF6478; Hemofiltrate peptide HF7665]	SPINK5	15464;	9606.ENSP00000352936;
P05412	JUN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transcription factor Jun (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (Transcription factor AP-1 subunit Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39)	JUN	6204;	9606.ENSP00000360266;
P21741	MK_HUMAN	reviewed	Evidence at protein level	5 out of 5	Midkine (MK) (Amphiregulin-associated protein) (ARAP) (Midgestation and kidney protein) (Neurite outgrowth-promoting factor 2) (Neurite outgrowth-promoting protein)	MDK MK1 NEGF2	6972;	9606.ENSP00000385451;
Q9H8L6	MMRN2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Multimerin-2 (EMILIN-3) (Elastin microfibril interface located protein 3) (Elastin microfibril interfacer 3) (EndoGlyx-1 p125/p140 subunit)	MMRN2 EMILIN3	19888;	9606.ENSP00000361097;
Q16539	MK14_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a)	MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A	6876;	9606.ENSP00000229795;
P43405	KSYK_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72-Syk)	SYK	11491;	9606.ENSP00000364907;
Q03001	DYST_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein)	DST BP230 BP240 BPAG1 DMH DT KIAA0728	1090;	9606.ENSP00000307959;
O95208	EPN2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Epsin-2 (EPS-15-interacting protein 2)	EPN2 KIAA1065	18639;	9606.ENSP00000320543;
Q13480	GAB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	GRB2-associated-binding protein 1 (GRB2-associated binder 1) (Growth factor receptor bound protein 2-associated protein 1)	GAB1	4066;	9606.ENSP00000262995;
Q16665	HIF1A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8)	HIF1A BHLHE78 MOP1 PASD8	4910;	9606.ENSP00000437955;
Q9BYM8	HOIL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 2.3.2.31) (HBV-associated factor 4) (Heme-oxidized IRP2 ubiquitin ligase 1) (HOIL-1) (Hepatitis B virus X-associated protein 4) (RING finger protein 54) (RING-type E3 ubiquitin transferase HOIL-1) (Ubiquitin-conjugating enzyme 7-interacting protein 3)	RBCK1 C20orf18 RNF54 UBCE7IP3 XAP3 XAP4	15864;	9606.ENSP00000348632;
Q9P266	JCAD_HUMAN	reviewed	Evidence at protein level	5 out of 5	Junctional protein associated with coronary artery disease (JCAD)	JCAD KIAA1462	29283;	9606.ENSP00000364526;
P17931	LEG3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Galectin-3 (Gal-3) (35 kDa lectin) (Carbohydrate-binding protein 35) (CBP 35) (Galactose-specific lectin 3) (Galactoside-binding protein) (GALBP) (IgE-binding protein) (L-31) (Laminin-binding protein) (Lectin L-29) (Mac-2 antigen)	LGALS3 MAC2	6563;	9606.ENSP00000254301;
O00182	LEG9_HUMAN	reviewed	Evidence at protein level	5 out of 5	Galectin-9 (Gal-9) (Ecalectin) (Tumor antigen HOM-HD-21)	LGALS9	6570;	9606.ENSP00000378856;
Q9Y4K0	LOXL2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lysyl oxidase homolog 2 (EC 1.4.3.13) (Lysyl oxidase-like protein 2) (Lysyl oxidase-related protein 2) (Lysyl oxidase-related protein WS9-14)	LOXL2	6666;	9606.ENSP00000373783;
Q6UXY1	BI2L2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 2 (BAI1-associated protein 2-like protein 2) (Planar intestinal- and kidney-specific BAR domain protein) (Pinkbar)	BAIAP2L2 UNQ9336/PRO34007	26203;	9606.ENSP00000371085;
Q14118	DAG1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dystroglycan 1 (Dystroglycan) (Dystrophin-associated glycoprotein 1) [Cleaved into: Alpha-dystroglycan (Alpha-DG); Beta-dystroglycan (Beta-DG)]	DAG1	2666;	9606.ENSP00000442600;
P54764	EPHA4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ephrin type-A receptor 4 (EC 2.7.10.1) (EPH-like kinase 8) (EK8) (hEK8) (Tyrosine-protein kinase TYRO1) (Tyrosine-protein kinase receptor SEK)	EPHA4 HEK8 SEK TYRO1	3388;	9606.ENSP00000281821;
P52789	HXK2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) (Hexokinase-B) (Muscle form hexokinase)	HK2	4923;	9606.ENSP00000290573;
P36222	CH3L1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Chitinase-3-like protein 1 (39 kDa synovial protein) (Cartilage glycoprotein 39) (CGP-39) (GP-39) (hCGP-39) (YKL-40)	CHI3L1	1932;	9606.ENSP00000255409;
P52799	EFNB2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ephrin-B2 (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L)	EFNB2 EPLG5 HTKL LERK5	3227;	9606.ENSP00000245323;
Q9NZ08	ERAP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Endoplasmic reticulum aminopeptidase 1 (EC 3.4.11.-) (ARTS-1) (Adipocyte-derived leucine aminopeptidase) (A-LAP) (Aminopeptidase PILS) (Puromycin-insensitive leucyl-specific aminopeptidase) (PILS-AP) (Type 1 tumor necrosis factor receptor shedding aminopeptidase regulator)	ERAP1 APPILS ARTS1 KIAA0525 UNQ584/PRO1154	18173;	9606.ENSP00000296754;
P29323	EPHB2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ephrin type-B receptor 2 (EC 2.7.10.1) (Developmentally-regulated Eph-related tyrosine kinase) (ELK-related tyrosine kinase) (EPH tyrosine kinase 3) (EPH-like kinase 5) (EK5) (hEK5) (Renal carcinoma antigen NY-REN-47) (Tyrosine-protein kinase TYRO5) (Tyrosine-protein kinase receptor EPH-3) [Cleaved into: EphB2/CTF1; EphB2/CTF2]	EPHB2 DRT EPHT3 EPTH3 ERK HEK5 TYRO5	3393;	9606.ENSP00000363763;
P14921	ETS1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein C-ets-1 (p54)	ETS1 EWSR2	3488;	9606.ENSP00000376436;
P10720	PF4V_HUMAN	reviewed	Evidence at protein level	5 out of 5	Platelet factor 4 variant (C-X-C motif chemokine 4 variant) (CXCL4L1) (PF4alt) (PF4var1) [Cleaved into: Platelet factor 4 variant(4-74); Platelet factor 4 variant(5-74); Platelet factor 4 variant(6-74)]	PF4V1 CXCL4V1 SCYB4V1	8862;	9606.ENSP00000226524;
Q9GZP0	PDGFD_HUMAN	reviewed	Evidence at protein level	5 out of 5	Platelet-derived growth factor D (PDGF-D) (Iris-expressed growth factor) (Spinal cord-derived growth factor B) (SCDGF-B) [Cleaved into: Platelet-derived growth factor D, latent form (PDGFD latent form); Platelet-derived growth factor D, receptor-binding form (PDGFD receptor-binding form)]	PDGFD IEGF SCDGFB MSTP036 UNQ1899/PRO4345	30620;	9606.ENSP00000376865;
Q9BUL8	PDC10_HUMAN	reviewed	Evidence at protein level	5 out of 5	Programmed cell death protein 10 (Cerebral cavernous malformations 3 protein) (TF-1 cell apoptosis-related protein 15)	PDCD10 CCM3 TFAR15	8761;	9606.ENSP00000376506;
O75340	PDCD6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Programmed cell death protein 6 (Apoptosis-linked gene 2 protein homolog) (ALG-2)	PDCD6 ALG2	8765;	9606.ENSP00000264933;
Q9Y4D7	PLXD1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Plexin-D1	PLXND1 KIAA0620	9107;	9606.ENSP00000317128;
P98177	FOXO4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Forkhead box protein O4 (Fork head domain transcription factor AFX1)	FOXO4 AFX AFX1 MLLT7	7139;	9606.ENSP00000363377;
P26006	ITA3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Integrin alpha-3 (CD49 antigen-like family member C) (FRP-2) (Galactoprotein B3) (GAPB3) (VLA-3 subunit alpha) (CD antigen CD49c) [Cleaved into: Integrin alpha-3 heavy chain; Integrin alpha-3 light chain]	ITGA3 MSK18	6139;	9606.ENSP00000007722;
P04264	K2C1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Keratin, type II cytoskeletal 1 (67 kDa cytokeratin) (Cytokeratin-1) (CK-1) (Hair alpha protein) (Keratin-1) (K1) (Type-II keratin Kb1)	KRT1 KRTA	6412;	9606.ENSP00000252244;
Q9UBM4	OPT_HUMAN	reviewed	Evidence at protein level	5 out of 5	Opticin (Oculoglycan)	OPTC OPT	8158;	9606.ENSP00000356191;
Q99542	MMP19_HUMAN	reviewed	Evidence at protein level	5 out of 5	Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix metalloproteinase RASI) (Matrix metalloproteinase-18) (MMP-18)	MMP19 MMP18 RASI	7165;	9606.ENSP00000313437;
Q13163	MP2K5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dual specificity mitogen-activated protein kinase kinase 5 (MAP kinase kinase 5) (MAPKK 5) (EC 2.7.12.2) (MAPK/ERK kinase 5) (MEK 5)	MAP2K5 MEK5 MKK5 PRKMK5	6845;	9606.ENSP00000178640;
O00443	P3C2A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.137) (EC 2.7.1.153) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha)	PIK3C2A	8971;	9606.ENSP00000265970;
Q9H2J4	PDCL3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Phosducin-like protein 3 (HTPHLP) (PhPL3) (Viral IAP-associated factor 1) (VIAF-1)	PDCL3 PhLP2A VIAF1	28860;	9606.ENSP00000264254;
Q13370	PDE3B_HUMAN	reviewed	Evidence at protein level	5 out of 5	cGMP-inhibited 3',5'-cyclic phosphodiesterase B (EC 3.1.4.17) (CGIPDE1) (CGIP1) (Cyclic GMP-inhibited phosphodiesterase B) (CGI-PDE B)	PDE3B	8779;	9606.ENSP00000282096;
P07585	PGS2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Decorin (Bone proteoglycan II) (PG-S2) (PG40)	DCN SLRR1B	2705;	9606.ENSP00000052754;
Q16236	NF2L2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nrf-2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2)	NFE2L2 NRF2	7782;	9606.ENSP00000380252;
P39060	COIA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Collagen alpha-1(XVIII) chain [Cleaved into: Endostatin; Non-collagenous domain 1 (NC1)]	COL18A1	2195;	
B0L3A2	DEAR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dual endothelin-1/angiotensin II receptor (Dear) (Dual endothelin-1/VEGFsp receptor) (DEspR protein) (FBXW7 antisense RNA 1)	FBXW7-AS1 DEAR DEspR	52397;	
P20719	HXA5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Homeobox protein Hox-A5 (Homeobox protein Hox-1C)	HOXA5 HOX1C	5106;	9606.ENSP00000222726;
Q96E22	NGBR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dehydrodolichyl diphosphate synthase complex subunit NUS1 (EC 2.5.1.87) (Cis-prenyltransferase subunit NgBR) (Nogo-B receptor) (NgBR) (Nuclear undecaprenyl pyrophosphate synthase 1 homolog)	NUS1 C6orf68 NGBR	21042;	9606.ENSP00000357480;
O76093	FGF18_HUMAN	reviewed	Evidence at protein level	5 out of 5	Fibroblast growth factor 18 (FGF-18) (zFGF5)	FGF18 UNQ420/PRO856	3674;	9606.ENSP00000274625;
Q9H334	FOXP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Forkhead box protein P1 (Mac-1-regulated forkhead) (MFH)	FOXP1 HSPC215	3823;	
O60462	NRP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Neuropilin-2 (Vascular endothelial cell growth factor 165 receptor 2)	NRP2 VEGF165R2	8005;	9606.ENSP00000353582;
P42785	PCP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lysosomal Pro-X carboxypeptidase (EC 3.4.16.2) (Angiotensinase C) (Lysosomal carboxypeptidase C) (Proline carboxypeptidase) (Prolylcarboxypeptidase) (PRCP)	PRCP PCP	9344;	9606.ENSP00000377055;
P41159	LEP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Leptin (Obese protein) (Obesity factor)	LEP OB OBS	6553;	9606.ENSP00000312652;
Q9BZL6	KPCD2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serine/threonine-protein kinase D2 (EC 2.7.11.13) (nPKC-D2)	PRKD2 PKD2 HSPC187	17293;	9606.ENSP00000393978;
Q8TB73	NDNF_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein NDNF (Neuron-derived neurotrophic factor)	NDNF C4orf31 UNQ2748/PRO6487	26256;	9606.ENSP00000369014;
P16581	LYAM2_HUMAN	reviewed	Evidence at protein level	5 out of 5	E-selectin (CD62 antigen-like family member E) (Endothelial leukocyte adhesion molecule 1) (ELAM-1) (Leukocyte-endothelial cell adhesion molecule 2) (LECAM2) (CD antigen CD62E)	SELE ELAM1	10718;	9606.ENSP00000331736;
P35354	PGH2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2)	PTGS2 COX2	9605;	9606.ENSP00000356438;
P54753	EPHB3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ephrin type-B receptor 3 (EC 2.7.10.1) (EPH-like tyrosine kinase 2) (EPH-like kinase 2) (Embryonic kinase 2) (EK2) (hEK2) (Tyrosine-protein kinase TYRO6)	EPHB3 ETK2 HEK2 TYRO6	3394;	9606.ENSP00000332118;
P14618	KPYM_HUMAN	reviewed	Evidence at protein level	5 out of 5	Pyruvate kinase PKM (EC 2.7.1.40) (Cytosolic thyroid hormone-binding protein) (CTHBP) (Opa-interacting protein 3) (OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Threonine-protein kinase PKM2) (EC 2.7.11.1) (Thyroid hormone-binding protein 1) (THBP1) (Tumor M2-PK) (Tyrosine-protein kinase PKM2) (EC 2.7.10.2) (p58)	PKM OIP3 PK2 PK3 PKM2	9021;	9606.ENSP00000320171;
P48357	LEPR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Leptin receptor (LEP-R) (HuB219) (OB receptor) (OB-R) (CD antigen CD295)	LEPR DB OBR	6554;	9606.ENSP00000330393;
O00522	KRIT1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Krev interaction trapped protein 1 (Krev interaction trapped 1) (Cerebral cavernous malformations 1 protein)	KRIT1 CCM1	1573;	9606.ENSP00000378015;
P06744	G6PI_HUMAN	reviewed	Evidence at protein level	5 out of 5	Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI) (Sperm antigen 36) (SA-36)	GPI	4458;	9606.ENSP00000405573;
O96004	HAND1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Heart- and neural crest derivatives-expressed protein 1 (Class A basic helix-loop-helix protein 27) (bHLHa27) (Extraembryonic tissues, heart, autonomic nervous system and neural crest derivatives-expressed protein 1) (eHAND)	HAND1 BHLHA27 EHAND	4807;	9606.ENSP00000231121;
P04792	HSPB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	5246;	9606.ENSP00000248553;
Q99958	FOXC2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Forkhead box protein C2 (Forkhead-related protein FKHL14) (Mesenchyme fork head protein 1) (MFH-1 protein) (Transcription factor FKH-14)	FOXC2 FKHL14 MFH1	3801;	9606.ENSP00000326371;
P05771	KPCB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13)	PRKCB PKCB PRKCB1	9395;	9606.ENSP00000305355;
P35579	MYH9_HUMAN	reviewed	Evidence at protein level	5 out of 5	Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA)	MYH9	7579;	9606.ENSP00000216181;
P50222	MEOX2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Homeobox protein MOX-2 (Growth arrest-specific homeobox) (Mesenchyme homeobox 2)	MEOX2 GAX MOX2	7014;	9606.ENSP00000262041;
Q9H204	MED28_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mediator of RNA polymerase II transcription subunit 28 (Endothelial-derived protein 1) (Mediator complex subunit 28) (Merlin and Grb2-interacting cytoskeletal protein) (Magicin) (Tumor angiogenesis marker EG-1)	MED28 EG1 FKSG20	24628;	9606.ENSP00000237380;
Q07075	AMPE_HUMAN	reviewed	Evidence at protein level	5 out of 5	Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (Differentiation antigen gp160) (CD antigen CD249)	ENPEP	3355;	9606.ENSP00000265162;
P03950	ANGI_HUMAN	reviewed	Evidence at protein level	5 out of 5	Angiogenin (EC 3.1.27.-) (Ribonuclease 5) (RNase 5)	ANG RNASE5	483;	9606.ENSP00000336762;
Q9UNI1	CELA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Chymotrypsin-like elastase family member 1 (EC 3.4.21.36) (Elastase-1) (Pancreatic elastase 1)	CELA1 ELA1	3308;	9606.ENSP00000293636;
P16860	ANFB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Natriuretic peptides B (Brain natriuretic factor prohormone) (preproBNP) (proBNP) (Gamma-brain natriuretic peptide) (Iso-ANP) [Cleaved into: NT-proBNP (NT-pro-BNP) (NT-proBNP(1-76)); proBNP(3-108); Brain natriuretic peptide 32 (BNP(1-32)) (BNP-32) (Brain natriuretic peptide) (BNP); BNP(1-30); BNP(1-29); BNP(1-28); BNP(2-31); BNP(3-32) (des-SerPro-BNP) (proBNP(79-108)); BNP(3-30); BNP(3-29); Brain natriuretic peptide 29 (BNP(4-32)); BNP(4-31); BNP(4-30); BNP(4-29); BNP(4-27); BNP(5-32); BNP(5-31); BNP(5-29)]	NPPB	7940;	9606.ENSP00000365651;
P60953	CDC42_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cell division control protein 42 homolog (EC 3.6.5.2) (G25K GTP-binding protein)	CDC42	1736;	9606.ENSP00000383118;
P14210	HGF_HUMAN	reviewed	Evidence at protein level	5 out of 5	Hepatocyte growth factor (Hepatopoietin-A) (Scatter factor) (SF) [Cleaved into: Hepatocyte growth factor alpha chain; Hepatocyte growth factor beta chain]	HGF HPTA	4893;	9606.ENSP00000222390;
P29459	IL12A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-12 subunit alpha (IL-12A) (Cytotoxic lymphocyte maturation factor 35 kDa subunit) (CLMF p35) (IL-12 subunit p35) (NK cell stimulatory factor chain 1) (NKSF1)	IL12A NKSF1	5969;	9606.ENSP00000303231;
P57087	JAM2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Junctional adhesion molecule B (JAM-B) (Junctional adhesion molecule 2) (JAM-2) (Vascular endothelial junction-associated molecule) (VE-JAM) (CD antigen CD322)	JAM2 C21orf43 VEJAM UNQ219/PRO245	14686;	9606.ENSP00000383376;
Q9BX67	JAM3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Junctional adhesion molecule C (JAM-C) (JAM-2) (Junctional adhesion molecule 3) (JAM-3) [Cleaved into: Soluble form of JAM-C (sJAM-C)]	JAM3 UNQ859/PRO1868	15532;	9606.ENSP00000299106;
P00558	PGK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Phosphoglycerate kinase 1 (EC 2.7.2.3) (Cell migration-inducing gene 10 protein) (Primer recognition protein 2) (PRP 2)	PGK1 PGKA MIG10 OK/SW-cl.110	8896;	9606.ENSP00000362413;
Q9P0K8	FOXJ2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Forkhead box protein J2 (Fork head homologous X)	FOXJ2 FHX	24818;	9606.ENSP00000162391;
Q30201	HFE_HUMAN	reviewed	Evidence at protein level	5 out of 5	Hereditary hemochromatosis protein (HLA-H)	HFE HLAH	4886;	9606.ENSP00000417404;
P18054	LOX12_HUMAN	reviewed	Evidence at protein level	5 out of 5	Polyunsaturated fatty acid lipoxygenase ALOX12 (EC 1.13.11.-) (Arachidonate (12S)-lipoxygenase) (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Arachidonate (15S)-lipoxygenase) (EC 1.13.11.33) (Linoleate (13S)-lipoxygenase) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12)	ALOX12 12LO LOG12	429;	9606.ENSP00000251535;
Q9BRP0	OVOL2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transcription factor Ovo-like 2 (hOvo2) (Zinc finger protein 339)	OVOL2 ZNF339	15804;	9606.ENSP00000278780;
Q6WN34	CRDL2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Chordin-like protein 2 (Breast tumor novel factor 1) (BNF-1) (Chordin-related protein 2)	CHRDL2 BNF1 CHL2 UNQ765/PRO1557	24168;	9606.ENSP00000263671;
P47928	ID4_HUMAN	reviewed	Evidence at protein level	5 out of 5	DNA-binding protein inhibitor ID-4 (Class B basic helix-loop-helix protein 27) (bHLHb27) (Inhibitor of DNA binding 4) (Inhibitor of differentiation 4)	ID4 BHLHB27	5363;	9606.ENSP00000367972;
P29460	IL12B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-12 subunit beta (IL-12B) (Cytotoxic lymphocyte maturation factor 40 kDa subunit) (CLMF p40) (IL-12 subunit p40) (NK cell stimulatory factor chain 2) (NKSF2)	IL12B NKSF2	5970;	9606.ENSP00000231228;
P18084	ITB5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Integrin beta-5	ITGB5	6160;	9606.ENSP00000296181;
Q9H4E5	RHOJ_HUMAN	reviewed	Evidence at protein level	5 out of 5	Rho-related GTP-binding protein RhoJ (Ras-like protein family member 7B) (Tc10-like GTP-binding protein)	RHOJ ARHJ RASL7B RHOI TCL	688;	9606.ENSP00000316729;
P14923	PLAK_HUMAN	reviewed	Evidence at protein level	5 out of 5	Junction plakoglobin (Catenin gamma) (Desmoplakin III) (Desmoplakin-3)	JUP CTNNG DP3	6207;	9606.ENSP00000377508;
O43927	CXL13_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-X-C motif chemokine 13 (Angie) (B cell-attracting chemokine 1) (BCA-1) (B lymphocyte chemoattractant) (CXC chemokine BLC) (Small-inducible cytokine B13)	CXCL13 BCA1 BLC SCYB13	10639;	9606.ENSP00000286758;
P46093	GPR4_HUMAN	reviewed	Evidence at protein level	5 out of 5	G-protein coupled receptor 4 (G-protein coupled receptor 6C.l) (GPR6C.l)	GPR4	4497;	9606.ENSP00000319744;
O60243	H6ST1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Heparan-sulfate 6-O-sulfotransferase 1 (HS6ST-1) (EC 2.8.2.-)	HS6ST1 HS6ST	5201;	9606.ENSP00000259241;
Q9Y251	HPSE_HUMAN	reviewed	Evidence at protein level	5 out of 5	Heparanase (EC 3.2.1.166) (Endo-glucoronidase) (Heparanase-1) (Hpa1) [Cleaved into: Heparanase 8 kDa subunit; Heparanase 50 kDa subunit]	HPSE HEP HPA HPA1 HPR1 HPSE1 HSE1	5164;	9606.ENSP00000384262;
Q9BXJ9	NAA15_HUMAN	reviewed	Evidence at protein level	5 out of 5	N-alpha-acetyltransferase 15, NatA auxiliary subunit (Gastric cancer antigen Ga19) (N-terminal acetyltransferase) (NMDA receptor-regulated protein 1) (Protein tubedown-1) (Tbdn100)	NAA15 GA19 NARG1 NATH TBDN100	30782;	9606.ENSP00000296543;
P42336	PK3CA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PI3-kinase subunit alpha) (PI3K-alpha) (PI3Kalpha) (PtdIns-3-kinase subunit alpha) (EC 2.7.1.137) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha) (PtdIns-3-kinase subunit p110-alpha) (p110alpha) (Phosphoinositide 3-kinase alpha) (Phosphoinositide-3-kinase catalytic alpha polypeptide) (Serine/threonine protein kinase PIK3CA) (EC 2.7.11.1)	PIK3CA	8975;	9606.ENSP00000263967;
Q96PD4	IL17F_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-17F (IL-17F) (Cytokine ML-1)	IL17F	16404;	9606.ENSP00000337432;
P19338	NUCL_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nucleolin (Protein C23)	NCL	7667;	9606.ENSP00000318195;
Q9NUU6	OTULL_HUMAN	reviewed	Evidence at protein level	5 out of 5	Inactive ubiquitin thioesterase OTULINL	OTULINL FAM105A	25629;	9606.ENSP00000274217;
Q92982	NINJ1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ninjurin-1 (Nerve injury-induced protein 1) [Cleaved into: Secreted ninjurin-1 (Soluble ninjurin-1)]	NINJ1	7824;	9606.ENSP00000364595;
P29474	NOS3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nitric oxide synthase, endothelial (EC 1.14.13.39) (Constitutive NOS) (cNOS) (EC-NOS) (Endothelial NOS) (eNOS) (NOS type III) (NOSIII)	NOS3	7876;	9606.ENSP00000297494;
P25116	PAR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Proteinase-activated receptor 1 (PAR-1) (Coagulation factor II receptor) (Thrombin receptor)	F2R CF2R PAR1 TR	3537;	9606.ENSP00000321326;
P61296	HAND2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Heart- and neural crest derivatives-expressed protein 2 (Class A basic helix-loop-helix protein 26) (bHLHa26) (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND)	HAND2 BHLHA26 DHAND	4808;	9606.ENSP00000352565;
Q9BZ23	PANK2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Pantothenate kinase 2, mitochondrial (hPanK2) (EC 2.7.1.33) (Pantothenic acid kinase 2) [Cleaved into: Pantothenate kinase 2, mitochondrial intermediate form (iPanK2); Pantothenate kinase 2, mitochondrial mature form (mPanK2)]	PANK2 C20orf48	15894;	9606.ENSP00000313377;
O14786	NRP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Neuropilin-1 (Vascular endothelial cell growth factor 165 receptor) (CD antigen CD304)	NRP1 NRP VEGF165R	8004;	9606.ENSP00000265371;
Q96T49	PP16B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein phosphatase 1 regulatory inhibitor subunit 16B (Ankyrin repeat domain-containing protein 4) (CAAX box protein TIMAP) (TGF-beta-inhibited membrane-associated protein) (hTIMAP)	PPP1R16B ANKRD4 KIAA0823	15850;	9606.ENSP00000299824;
Q9HC23	PROK2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prokineticin-2 (PK2) (Protein Bv8 homolog)	PROK2 BV8	18455;	9606.ENSP00000295619;
Q13153	PAK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	8590;	9606.ENSP00000278568;
P08648	ITA5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Integrin alpha-5 (CD49 antigen-like family member E) (Fibronectin receptor subunit alpha) (Integrin alpha-F) (VLA-5) (CD antigen CD49e) [Cleaved into: Integrin alpha-5 heavy chain; Integrin alpha-5 light chain]	ITGA5 FNRA	6141;	9606.ENSP00000293379;
P26012	ITB8_HUMAN	reviewed	Evidence at protein level	5 out of 5	Integrin beta-8	ITGB8	6163;	9606.ENSP00000222573;
Q96BN8	OTUL_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ubiquitin thioesterase otulin (EC 3.4.19.12) (Deubiquitinating enzyme otulin) (OTU domain-containing deubiquitinase with linear linkage specificity) (Ubiquitin thioesterase Gumby)	OTULIN FAM105B	25118;	9606.ENSP00000284274;
Q92569	P55G_HUMAN	reviewed	Evidence at protein level	5 out of 5	Phosphatidylinositol 3-kinase regulatory subunit gamma (PI3-kinase regulatory subunit gamma) (PI3K regulatory subunit gamma) (PtdIns-3-kinase regulatory subunit gamma) (Phosphatidylinositol 3-kinase 55 kDa regulatory subunit gamma) (PI3-kinase subunit p55-gamma) (PtdIns-3-kinase regulatory subunit p55-gamma) (p55PIK)	PIK3R3	8981;	9606.ENSP00000262741;
Q8N264	RHG24_HUMAN	reviewed	Evidence at protein level	5 out of 5	Rho GTPase-activating protein 24 (Filamin-A-associated RhoGAP) (FilGAP) (RAC1- and CDC42-specific GTPase-activating protein of 72 kDa) (RC-GAP72) (Rho-type GTPase-activating protein 24) (RhoGAP of 73 kDa) (Sarcoma antigen NY-SAR-88) (p73RhoGAP)	ARHGAP24 FILGAP	25361;	9606.ENSP00000378611;
P38398	BRCA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1)	BRCA1 RNF53	1100;	9606.ENSP00000418960;
O95389	CCN6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cellular communication network factor 6 (CCN family member 6) (WNT1-inducible-signaling pathway protein 3) (WISP-3)	CCN6 WISP3 UNQ462/PRO790/PRO956	12771;	9606.ENSP00000357655;
Q9ULV1	FZD4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Frizzled-4 (Fz-4) (hFz4) (FzE4) (CD antigen CD344)	FZD4	4042;	9606.ENSP00000434034;
Q13467	FZD5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Frizzled-5 (Fz-5) (hFz5) (FzE5)	FZD5 C2orf31	4043;	9606.ENSP00000354607;
P23769	GATA2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Endothelial transcription factor GATA-2 (GATA-binding protein 2)	GATA2	4171;	9606.ENSP00000345681;
Q9H461	FZD8_HUMAN	reviewed	Evidence at protein level	5 out of 5	Frizzled-8 (Fz-8) (hFz8)	FZD8	4046;	9606.ENSP00000363826;
P43694	GATA4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transcription factor GATA-4 (GATA-binding factor 4)	GATA4	4173;	9606.ENSP00000334458;
Q92908	GATA6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transcription factor GATA-6 (GATA-binding factor 6)	GATA6	4174;	9606.ENSP00000269216;
P54851	EMP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Epithelial membrane protein 2 (EMP-2) (Protein XMP)	EMP2 XMP	3334;	9606.ENSP00000352540;
Q9P2N4	ATS9_HUMAN	reviewed	Evidence at protein level	5 out of 5	A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-)	ADAMTS9 KIAA1312	13202;	9606.ENSP00000418735;
O95760	IL33_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-33 (IL-33) (Interleukin-1 family member 11) (IL-1F11) (Nuclear factor from high endothelial venules) (NF-HEV) [Cleaved into: Interleukin-33 (95-270); Interleukin-33 (99-270); Interleukin-33 (109-270)]	IL33 C9orf26 IL1F11 NFHEV	16028;	9606.ENSP00000370842;
Q92743	HTRA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serine protease HTRA1 (EC 3.4.21.-) (High-temperature requirement A serine peptidase 1) (L56) (Serine protease 11)	HTRA1 HTRA PRSS11	9476;	9606.ENSP00000357980;
Q9Y2M5	KLH20_HUMAN	reviewed	Evidence at protein level	5 out of 5	Kelch-like protein 20 (Kelch-like ECT2-interacting protein) (Kelch-like protein X)	KLHL20 KLEIP KLHLX	25056;	9606.ENSP00000209884;
Q8N8U9	BMPER_HUMAN	reviewed	Evidence at protein level	5 out of 5	BMP-binding endothelial regulator protein (Bone morphogenetic protein-binding endothelial cell precursor-derived regulator) (Protein crossveinless-2) (hCV2)	BMPER KIAA1965	24154;	9606.ENSP00000297161;
Q9UHR4	BI2L1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1 (BAI1-associated protein 2-like protein 1) (Insulin receptor tyrosine kinase substrate)	BAIAP2L1 IRTKS	21649;	9606.ENSP00000005260;
Q14209	E2F2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transcription factor E2F2 (E2F-2)	E2F2	3114;	9606.ENSP00000355249;
Q96AV8	E2F7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transcription factor E2F7 (E2F-7)	E2F7	23820;	9606.ENSP00000323246;
A0AVK6	E2F8_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transcription factor E2F8 (E2F-8)	E2F8	24727;	9606.ENSP00000481103;
P52797	EFNA3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ephrin-A3 (EFL-2) (EHK1 ligand) (EHK1-L) (EPH-related receptor tyrosine kinase ligand 3) (LERK-3)	EFNA3 EFL2 EPLG3 LERK3	3223;	9606.ENSP00000357393;
P48745	CCN3_HUMAN	reviewed	Evidence at protein level	5 out of 5	CCN family member 3 (Cellular communication network factor 3) (Insulin-like growth factor-binding protein 9) (IBP-9) (IGF-binding protein 9) (IGFBP-9) (Nephro blastoma-overexpressed gene protein homolog) (Protein NOV homolog) (NovH)	CCN3 IGFBP9 NOV NOVH	7885;	9606.ENSP00000259526;
P51677	CCR3_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C chemokine receptor type 3 (C C CKR3) (C-C CKR-3) (CC-CKR-3) (CCR-3) (CCR3) (CKR 3) (CKR3) (Eosinophil eotaxin receptor) (CD antigen CD193)	CCR3 CMKBR3	1604;	9606.ENSP00000441600;
Q9BU40	CRDL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Chordin-like protein 1 (Neuralin-1) (Neurogenesin-1) (Ventroptin)	CHRDL1 NRLN1	29861;	9606.ENSP00000361112;
Q9UBU3	GHRL_HUMAN	reviewed	Evidence at protein level	5 out of 5	Appetite-regulating hormone (Growth hormone secretagogue) (Growth hormone-releasing peptide) (Motilin-related peptide) (Protein M46) [Cleaved into: Ghrelin-27; Ghrelin-28 (Ghrelin); Obestatin]	GHRL MTLRP UNQ524/PRO1066	18129;	9606.ENSP00000335074;
Q92847	GHSR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor)	GHSR	4267;	9606.ENSP00000241256;
P20827	EFNA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ephrin-A1 (EPH-related receptor tyrosine kinase ligand 1) (LERK-1) (Immediate early response protein B61) (Tumor necrosis factor alpha-induced protein 4) (TNF alpha-induced protein 4) [Cleaved into: Ephrin-A1, secreted form]	EFNA1 EPLG1 LERK1 TNFAIP4	3221;	9606.ENSP00000357392;
P01133	EGF_HUMAN	reviewed	Evidence at protein level	5 out of 5	Pro-epidermal growth factor (EGF) [Cleaved into: Epidermal growth factor (Urogastrone)]	EGF	3229;	9606.ENSP00000265171;
P13500	CCL2_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C motif chemokine 2 (HC11) (Monocyte chemoattractant protein 1) (Monocyte chemotactic and activating factor) (MCAF) (Monocyte chemotactic protein 1) (MCP-1) (Monocyte secretory protein JE) (Small-inducible cytokine A2)	CCL2 MCP1 SCYA2	10618;	9606.ENSP00000225831;
P13688	CEAM1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Carcinoembryonic antigen-related cell adhesion molecule 1 (Biliary glycoprotein 1) (BGP-1) (CD antigen CD66a)	CEACAM1 BGP BGP1	1814;	9606.ENSP00000161559;
Q9UK97	FBX9_HUMAN	reviewed	Evidence at protein level	5 out of 5	F-box only protein 9 (Cross-immune reaction antigen 1) (Renal carcinoma antigen NY-REN-57)	FBXO9 FBX9 VCIA1	13588;	9606.ENSP00000244426;
Q4L180	FIL1L_HUMAN	reviewed	Evidence at protein level	5 out of 5	Filamin A-interacting protein 1-like (130 kDa GPBP-interacting protein) (90 kDa GPBP-interacting protein) (Protein down-regulated in ovarian cancer 1) (DOC-1)	FILIP1L COL4A3BPIP DOC1 GIP90	24589;	9606.ENSP00000346560;
O00548	DLL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Delta-like protein 1 (Drosophila Delta homolog 1) (Delta1) (H-Delta-1)	DLL1 UNQ146/PRO172	2908;	9606.ENSP00000355718;
P21333	FLNA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin)	FLNA FLN FLN1	3754;	9606.ENSP00000358866;
P02751	FINC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Fibronectin (FN) (Cold-insoluble globulin) (CIG) [Cleaved into: Anastellin; Ugl-Y1; Ugl-Y2; Ugl-Y3]	FN1 FN	3778;	9606.ENSP00000346839;
Q12948	FOXC1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Forkhead box protein C1 (Forkhead-related protein FKHL7) (Forkhead-related transcription factor 3) (FREAC-3)	FOXC1 FKHL7 FREAC3	3800;	9606.ENSP00000370256;
P29279	CCN2_HUMAN	reviewed	Evidence at protein level	5 out of 5	CCN family member 2 (Cellular communication network factor 2) (Connective tissue growth factor) (Hypertrophic chondrocyte-specific protein 24) (Insulin-like growth factor-binding protein 8) (IBP-8) (IGF-binding protein 8) (IGFBP-8)	CCN2 CTGF HCS24 IGFBP8	2500;	9606.ENSP00000356954;
P16671	CD36_HUMAN	reviewed	Evidence at protein level	5 out of 5	Platelet glycoprotein 4 (Fatty acid translocase) (FAT) (Glycoprotein IIIb) (GPIIIB) (Leukocyte differentiation antigen CD36) (PAS IV) (PAS-4) (Platelet collagen receptor) (Platelet glycoprotein IV) (GPIV) (Thrombospondin receptor) (CD antigen CD36)	CD36 GP3B GP4	1663;	9606.ENSP00000399421;
P24522	GA45A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Growth arrest and DNA damage-inducible protein GADD45 alpha (DNA damage-inducible transcript 1 protein) (DDIT-1)	GADD45A DDIT1 GADD45	4095;	9606.ENSP00000360025;
P29317	EPHA2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ephrin type-A receptor 2 (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK)	EPHA2 ECK	3386;	9606.ENSP00000351209;
Q8IVF7	FMNL3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Formin-like protein 3 (Formin homology 2 domain-containing protein 3) (WW domain-binding protein 3) (WBP-3)	FMNL3 FHOD3 FRL2 KIAA2014 WBP3	23698;	9606.ENSP00000335655;
P36382	CXA5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Gap junction alpha-5 protein (Connexin-40) (Cx40)	GJA5	4279;	9606.ENSP00000484552;
P25067	CO8A2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Collagen alpha-2(VIII) chain (Endothelial collagen)	COL8A2	2216;	9606.ENSP00000380901;
P01031	CO5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Complement C5 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4) [Cleaved into: Complement C5 beta chain; Complement C5 alpha chain; C5a anaphylatoxin; Complement C5 alpha' chain]	C5 CPAMD4	1331;	9606.ENSP00000223642;
P02778	CXL10_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-X-C motif chemokine 10 (10 kDa interferon gamma-induced protein) (Gamma-IP10) (IP-10) (Small-inducible cytokine B10) [Cleaved into: CXCL10(1-73)]	CXCL10 INP10 SCYB10	10637;	9606.ENSP00000305651;
Q12841	FSTL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Follistatin-related protein 1 (Follistatin-like protein 1)	FSTL1 FRP	3972;	9606.ENSP00000295633;
P06756	ITAV_HUMAN	reviewed	Evidence at protein level	5 out of 5	Integrin alpha-V (Vitronectin receptor) (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain]	ITGAV MSK8 VNRA VTNR	6150;	9606.ENSP00000261023;
Q6UXH8	CCBE1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Collagen and calcium-binding EGF domain-containing protein 1 (Full of fluid protein homolog)	CCBE1 KIAA1983 UNQ1921/PRO4395	29426;	9606.ENSP00000404464;
Q19T08	ECSCR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Endothelial cell-specific chemotaxis regulator (Apoptosis regulator through modulating IAP expression) (ARIA) (Endothelial cell-specific molecule 2)	ECSCR ECSM2	35454;	9606.ENSP00000479243;
Q969H0	FBXW7_HUMAN	reviewed	Evidence at protein level	5 out of 5	F-box/WD repeat-containing protein 7 (Archipelago homolog) (hAgo) (F-box and WD-40 domain-containing protein 7) (F-box protein FBX30) (SEL-10) (hCdc4)	FBXW7 FBW7 FBX30 SEL10	16712;	9606.ENSP00000281708;
P35613	BASI_HUMAN	reviewed	Evidence at protein level	5 out of 5	Basigin (5F7) (Collagenase stimulatory factor) (Extracellular matrix metalloproteinase inducer) (EMMPRIN) (Hepatoma-associated antigen) (HAb18G) (Leukocyte activation antigen M6) (OK blood group antigen) (Tumor cell-derived collagenase stimulatory factor) (TCSF) (CD antigen CD147)	BSG UNQ6505/PRO21383	1116;	9606.ENSP00000333769;
P22004	BMP6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Bone morphogenetic protein 6 (BMP-6) (VG-1-related protein) (VG-1-R) (VGR-1)	BMP6 VGR	1073;	9606.ENSP00000283147;
P80075	CCL8_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C motif chemokine 8 (HC14) (Monocyte chemoattractant protein 2) (Monocyte chemotactic protein 2) (MCP-2) (Small-inducible cytokine A8) [Cleaved into: MCP-2(6-76)]	CCL8 MCP2 SCYA10 SCYA8	10635;	9606.ENSP00000378118;
Q9NZV1	CRIM1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cysteine-rich motor neuron 1 protein (CRIM-1) (Cysteine-rich repeat-containing protein S52) [Cleaved into: Processed cysteine-rich motor neuron 1 protein]	CRIM1 S52 UNQ1886/PRO4330	2359;	9606.ENSP00000280527;
P01588	EPO_HUMAN	reviewed	Evidence at protein level	5 out of 5	Erythropoietin (Epoetin)	EPO	3415;	9606.ENSP00000252723;
P00519	ABL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150)	ABL1 ABL JTK7	76;	9606.ENSP00000361423;
P25106	ACKR3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Atypical chemokine receptor 3 (C-X-C chemokine receptor type 7) (CXC-R7) (CXCR-7) (Chemokine orphan receptor 1) (G-protein coupled receptor 159) (G-protein coupled receptor RDC1 homolog) (RDC-1)	ACKR3 CMKOR1 CXCR7 GPR159 RDC1	23692;	9606.ENSP00000272928;
Q9Y653	AGRG1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adhesion G-protein coupled receptor G1 (G-protein coupled receptor 56) (Protein TM7XN1) [Cleaved into: ADGRG1 N-terminal fragment (ADGRG1 NT) (GPR56 N-terminal fragment) (GPR56 NT) (GPR56(N)) (GPR56 extracellular subunit) (GPR56 subunit alpha); ADGRG1 C-terminal fragment (ADGRG1 CT) (GPR56 C-terminal fragment) (GPR56 CT) (GPR56(C)) (GPR56 seven-transmembrane subunit) (GPR56 7TM) (GPR56 subunit beta)]	ADGRG1 GPR56 TM7LN4 TM7XN1 UNQ540/PRO1083	4512;	9606.ENSP00000455215;
Q13443	ADAM9_HUMAN	reviewed	Evidence at protein level	5 out of 5	Disintegrin and metalloproteinase domain-containing protein 9 (ADAM 9) (EC 3.4.24.-) (Cellular disintegrin-related protein) (Meltrin-gamma) (Metalloprotease/disintegrin/cysteine-rich protein 9) (Myeloma cell metalloproteinase)	ADAM9 KIAA0021 MCMP MDC9 MLTNG	216;	9606.ENSP00000419446;
Q9Y264	ANGP4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Angiopoietin-4 (ANG-4) (Angiopoietin-3) (ANG-3)	ANGPT4 ANG3 ANG4	487;	9606.ENSP00000371347;
P41597	CCR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C chemokine receptor type 2 (C-C CKR-2) (CC-CKR-2) (CCR-2) (CCR2) (Monocyte chemoattractant protein 1 receptor) (MCP-1-R) (CD antigen CD192)	CCR2 CMKBR2	1603;	9606.ENSP00000292301;
Q9UHN6	CEIP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cell surface hyaluronidase (EC 3.2.1.35) (Cell migration-inducing hyaluronidase 2) (Transmembrane protein 2)	CEMIP2 KIAA1412 TMEM2	11869;	9606.ENSP00000366243;
P27658	CO8A1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Collagen alpha-1(VIII) chain (Endothelial collagen) [Cleaved into: Vastatin]	COL8A1 C3orf7	2215;	9606.ENSP00000261037;
Q14790	CASP8_HUMAN	reviewed	Evidence at protein level	5 out of 5	Caspase-8 (CASP-8) (EC 3.4.22.61) (Apoptotic cysteine protease) (Apoptotic protease Mch-5) (CAP4) (FADD-homologous ICE/ced-3-like protease) (FADD-like ICE) (FLICE) (ICE-like apoptotic protease 5) (MORT1-associated ced-3 homolog) (MACH) [Cleaved into: Caspase-8 subunit p18; Caspase-8 subunit p10]	CASP8 MCH5	1509;	9606.ENSP00000351273;
P09668	CATH_HUMAN	reviewed	Evidence at protein level	5 out of 5	Pro-cathepsin H [Cleaved into: Cathepsin H mini chain; Cathepsin H (EC 3.4.22.16); Cathepsin H heavy chain; Cathepsin H light chain]	CTSH CPSB	2535;	9606.ENSP00000220166;
P49913	CAMP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cathelicidin antimicrobial peptide (18 kDa cationic antimicrobial protein) (CAP-18) (hCAP-18) [Cleaved into: Antibacterial peptide FALL-39 (FALL-39 peptide antibiotic); Antibacterial peptide LL-37]	CAMP CAP18 FALL39 HSD26	1472;	9606.ENSP00000296435;
P78352	DLG4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Disks large homolog 4 (Postsynaptic density protein 95) (PSD-95) (Synapse-associated protein 90) (SAP-90) (SAP90)	DLG4 PSD95	2903;	9606.ENSP00000382428;
P41970	ELK3_HUMAN	reviewed	Evidence at protein level	5 out of 5	ETS domain-containing protein Elk-3 (ETS-related protein ERP) (ETS-related protein NET) (Serum response factor accessory protein 2) (SAP-2) (SRF accessory protein 2)	ELK3 NET SAP2	3325;	9606.ENSP00000228741;
Q9GZT9	EGLN1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Egl nine homolog 1 (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 2) (HIF-PH2) (HIF-prolyl hydroxylase 2) (HPH-2) (Prolyl hydroxylase domain-containing protein 2) (PHD2) (SM-20)	EGLN1 C1orf12 PNAS-118 PNAS-137	1232;	9606.ENSP00000355601;
Q86UE4	LYRIC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein LYRIC (3D3/LYRIC) (Astrocyte elevated gene-1 protein) (AEG-1) (Lysine-rich CEACAM1 co-isolated protein) (Metadherin) (Metastasis adhesion protein)	MTDH AEG1 LYRIC	29608;	9606.ENSP00000338235;
P04839	CY24B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cytochrome b-245 heavy chain (EC 1.-.-.-) (CGD91-phox) (Cytochrome b(558) subunit beta) (Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)	CYBB NOX2	2578;	9606.ENSP00000367851;
Q9Y6I3	EPN1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Epsin-1 (EH domain-binding mitotic phosphoprotein) (EPS-15-interacting protein 1)	EPN1	21604;	9606.ENSP00000406209;
Q8N6P7	I22R1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-22 receptor subunit alpha-1 (IL-22 receptor subunit alpha-1) (IL-22R-alpha-1) (IL-22RA1) (Cytokine receptor class-II member 9) (Cytokine receptor family 2 member 9) (CRF2-9) (ZcytoR11)	IL22RA1 IL22R	13700;	9606.ENSP00000270800;
P05106	ITB3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Integrin beta-3 (Platelet membrane glycoprotein IIIa) (GPIIIa) (CD antigen CD61)	ITGB3 GP3A	6156;	9606.ENSP00000452786;
Q9NQ30	ESM1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Endothelial cell-specific molecule 1 (ESM-1)	ESM1	3466;	9606.ENSP00000370812;
P09038	FGF2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Fibroblast growth factor 2 (FGF-2) (Basic fibroblast growth factor) (bFGF) (Heparin-binding growth factor 2) (HBGF-2)	FGF2 FGFB	3676;	9606.ENSP00000264498;
P09601	HMOX1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Heme oxygenase 1 (HO-1) (EC 1.14.14.18) [Cleaved into: Heme oxygenase 1 soluble form]	HMOX1 HO HO1	5013;	9606.ENSP00000216117;
P52926	HMGA2_HUMAN	reviewed	Evidence at protein level	5 out of 5	High mobility group protein HMGI-C (High mobility group AT-hook protein 2)	HMGA2 HMGIC	5009;	9606.ENSP00000437621;
Q9Y5J3	HEY1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Hairy/enhancer-of-split related with YRPW motif protein 1 (Cardiovascular helix-loop-helix factor 2) (CHF-2) (Class B basic helix-loop-helix protein 31) (bHLHb31) (HES-related repressor protein 1) (Hairy and enhancer of split-related protein 1) (HESR-1) (Hairy-related transcription factor 1) (HRT-1) (hHRT1)	HEY1 BHLHB31 CHF2 HERP2 HESR1 HRT1	4880;	9606.ENSP00000338272;
Q9NS00	C1GLT_HUMAN	reviewed	Evidence at protein level	5 out of 5	Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (B3Gal-T8) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Beta-1,3-galactosyltransferase) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1)	C1GALT1	24337;	9606.ENSP00000389176;
Q16678	CP1B1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cytochrome P450 1B1 (EC 1.14.14.1) (CYPIB1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)	CYP1B1	2597;	9606.ENSP00000478561;
O15520	FGF10_HUMAN	reviewed	Evidence at protein level	5 out of 5	Fibroblast growth factor 10 (FGF-10) (Keratinocyte growth factor 2)	FGF10	3666;	9606.ENSP00000264664;
P18510	IL1RA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-1 receptor antagonist protein (IL-1RN) (IL-1ra) (IRAP) (ICIL-1RA) (IL1 inhibitor) (Anakinra)	IL1RN IL1F3 IL1RA	6000;	9606.ENSP00000259206;
Q9NYY1	IL20_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-20 (IL-20) (Cytokine Zcyto10)	IL20 ZCYTO10 UNQ852/PRO1801	6002;	9606.ENSP00000356065;
Q12794	HYAL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Hyaluronidase-1 (Hyal-1) (EC 3.2.1.35) (Hyaluronoglucosaminidase-1) (Lung carcinoma protein 1) (LuCa-1)	HYAL1 LUCA1	5320;	9606.ENSP00000266031;
Q02535	ID3_HUMAN	reviewed	Evidence at protein level	5 out of 5	DNA-binding protein inhibitor ID-3 (Class B basic helix-loop-helix protein 25) (bHLHb25) (Helix-loop-helix protein HEIR-1) (ID-like protein inhibitor HLH 1R21) (Inhibitor of DNA binding 3) (Inhibitor of differentiation 3)	ID3 1R21 BHLHB25 HEIR1	5362;	9606.ENSP00000363689;
Q16610	ECM1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Extracellular matrix protein 1 (Secretory component p85)	ECM1	3153;	9606.ENSP00000358045;
Q5UCC4	EMC10_HUMAN	reviewed	Evidence at protein level	5 out of 5	ER membrane protein complex subunit 10 (Hematopoietic signal peptide-containing membrane domain-containing protein 1)	EMC10 C19orf63 INM02 UNQ764/PRO1556	27609;	9606.ENSP00000334037;
Q9Y6C2	EMIL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	EMILIN-1 (Elastin microfibril interface-located protein 1) (Elastin microfibril interfacer 1)	EMILIN1 EMI	19880;	9606.ENSP00000369677;
Q9BXX0	EMIL2_HUMAN	reviewed	Evidence at protein level	5 out of 5	EMILIN-2 (Elastin microfibril interface-located protein 2) (Elastin microfibril interfacer 2) (Protein FOAP-10)	EMILIN2	19881;	9606.ENSP00000254528;
O14944	EREG_HUMAN	reviewed	Evidence at protein level	5 out of 5	Proepiregulin [Cleaved into: Epiregulin (EPR)]	EREG	3443;	9606.ENSP00000244869;
Q6UXB2	CXL17_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-X-C motif chemokine 17 (6-Cys CXCL17) (Dendritic cell and monocyte chemokine-like protein) (DMC) (VEGF coregulated chemokine 1) [Cleaved into: 4-Cys CXCL17]	CXCL17 VCC1 UNQ473/PRO842	19232;	9606.ENSP00000472467;
Q9UQL6	HDAC5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histone deacetylase 5 (HD5) (EC 3.5.1.98) (Antigen NY-CO-9)	HDAC5 KIAA0600	14068;	9606.ENSP00000225983;
Q8WUI4	HDAC7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histone deacetylase 7 (HD7) (EC 3.5.1.98) (Histone deacetylase 7A) (HD7a)	HDAC7 HDAC7A	14067;	9606.ENSP00000080059;
Q9UKV0	HDAC9_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histone deacetylase 9 (HD9) (EC 3.5.1.98) (Histone deacetylase 7B) (HD7) (HD7b) (Histone deacetylase-related protein) (MEF2-interacting transcription repressor MITR)	HDAC9 HDAC7 HDAC7B HDRP KIAA0744 MITR	14065;	9606.ENSP00000408617;
Q14289	FAK2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2) (Related adhesion focal tyrosine kinase) (RAFTK)	PTK2B FAK2 PYK2 RAFTK	9612;	9606.ENSP00000380638;
Q9UII2	ATIF1_HUMAN	reviewed	Evidence at protein level	5 out of 5	ATPase inhibitor, mitochondrial (ATP synthase F1 subunit epsilon) (Inhibitor of F(1)F(o)-ATPase) (IF(1)) (IF1)	ATP5IF1 ATPI ATPIF1	871;	9606.ENSP00000335203;
Q9NQC7	CYLD_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD)	CYLD CYLD1 KIAA0849 HSPC057	2584;	9606.ENSP00000392025;
P78347	GTF2I_HUMAN	reviewed	Evidence at protein level	5 out of 5	General transcription factor II-I (GTFII-I) (TFII-I) (Bruton tyrosine kinase-associated protein 135) (BAP-135) (BTK-associated protein 135) (SRF-Phox1-interacting protein) (SPIN) (Williams-Beuren syndrome chromosomal region 6 protein)	GTF2I BAP135 WBSCR6	4659;	9606.ENSP00000460070;
Q92826	HXB13_HUMAN	reviewed	Evidence at protein level	5 out of 5	Homeobox protein Hox-B13	HOXB13	5112;	9606.ENSP00000290295;
Q14116	IL18_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-18 (IL-18) (Iboctadekin) (Interferon gamma-inducing factor) (IFN-gamma-inducing factor) (Interleukin-1 gamma) (IL-1 gamma)	IL18 IGIF IL1F4	5986;	9606.ENSP00000280357;
P39059	COFA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Collagen alpha-1(XV) chain [Cleaved into: Restin (Endostatin-XV) (Related to endostatin) (Restin-I); Restin-2 (Restin-II); Restin-3 (Restin-III); Restin-4 (Restin-IV)]	COL15A1	2192;	9606.ENSP00000364140;
Q9UHW9	S12A6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Solute carrier family 12 member 6 (Electroneutral potassium-chloride cotransporter 3) (K-Cl cotransporter 3)	SLC12A6 KCC3	10914;	9606.ENSP00000346112;
Q9NQ36	SCUB2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You)	SCUBE2 CEGP1	30425;	9606.ENSP00000429969;
Q9NRA2	S17A5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)	SLC17A5	10933;	9606.ENSP00000348019;
P21453	S1PR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Sphingosine 1-phosphate receptor 1 (S1P receptor 1) (S1P1) (Endothelial differentiation G-protein coupled receptor 1) (Sphingosine 1-phosphate receptor Edg-1) (S1P receptor Edg-1) (CD antigen CD363)	S1PR1 CHEDG1 EDG1	3165;	9606.ENSP00000305416;
Q16602	CALRL_HUMAN	reviewed	Evidence at protein level	5 out of 5	Calcitonin gene-related peptide type 1 receptor (CGRP type 1 receptor) (Calcitonin receptor-like receptor)	CALCRL CGRPR	16709;	9606.ENSP00000386972;
P28906	CD34_HUMAN	reviewed	Evidence at protein level	5 out of 5	Hematopoietic progenitor cell antigen CD34 (CD antigen CD34)	CD34	1662;	9606.ENSP00000310036;
Q13822	ENPP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (E-NPP 2) (EC 3.1.4.39) (Autotaxin) (Extracellular lysophospholipase D) (LysoPLD)	ENPP2 ATX PDNP2	3357;	9606.ENSP00000259486;
O94760	DDAH1_HUMAN	reviewed	Evidence at protein level	5 out of 5	N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (DDAH-1) (Dimethylarginine dimethylaminohydrolase 1) (EC 3.5.3.18) (DDAHI) (Dimethylargininase-1)	DDAH1 DDAH	2715;	9606.ENSP00000284031;
P31268	HXA7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Homeobox protein Hox-A7 (Homeobox protein Hox 1.1) (Homeobox protein Hox-1A)	HOXA7 HOX1A	5108;	9606.ENSP00000242159;
P05231	IL6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-6 (IL-6) (B-cell stimulatory factor 2) (BSF-2) (CTL differentiation factor) (CDF) (Hybridoma growth factor) (Interferon beta-2) (IFN-beta-2)	IL6 IFNB2	6018;	9606.ENSP00000385675;
Q9UNL4	ING4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Inhibitor of growth protein 4 (p29ING4)	ING4 My036	19423;	9606.ENSP00000380024;
O14713	ITBP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Integrin beta-1-binding protein 1 (Integrin cytoplasmic domain-associated protein 1) (ICAP-1)	ITGB1BP1 ICAP1	23927;	9606.ENSP00000353850;
Q15648	MED1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mediator of RNA polymerase II transcription subunit 1 (Activator-recruited cofactor 205 kDa component) (ARC205) (Mediator complex subunit 1) (Peroxisome proliferator-activated receptor-binding protein) (PBP) (PPAR-binding protein) (Thyroid hormone receptor-associated protein complex 220 kDa component) (Trap220) (Thyroid receptor-interacting protein 2) (TR-interacting protein 2) (TRIP-2) (Vitamin D receptor-interacting protein complex component DRIP205) (p53 regulatory protein RB18A)	MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2	9234;	9606.ENSP00000300651;
Q99759	M3K3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mitogen-activated protein kinase kinase kinase 3 (EC 2.7.11.25) (MAPK/ERK kinase kinase 3) (MEK kinase 3) (MEKK 3)	MAP3K3 MAPKKK3 MEKK3	6855;	9606.ENSP00000354927;
Q9Y466	NR2E1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nuclear receptor subfamily 2 group E member 1 (Nuclear receptor TLX) (Protein tailless homolog) (Tll) (hTll)	NR2E1 TLX	7973;	9606.ENSP00000357979;
P09619	PGFRB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1) (PDGFR-1) (CD antigen CD140b)	PDGFRB PDGFR PDGFR1	8804;	9606.ENSP00000261799;
O95997	PTTG1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Securin (Esp1-associated protein) (Pituitary tumor-transforming gene 1 protein) (Tumor-transforming protein 1) (hPTTG)	PTTG1 EAP1 PTTG TUTR1	9690;	9606.ENSP00000377536;
P28827	PTPRM_HUMAN	reviewed	Evidence at protein level	5 out of 5	Receptor-type tyrosine-protein phosphatase mu (Protein-tyrosine phosphatase mu) (R-PTP-mu) (EC 3.1.3.48)	PTPRM PTPRL1	9675;	9606.ENSP00000463325;
P60484	PTEN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)	PTEN MMAC1 TEP1	9588;	9606.ENSP00000361021;
O96013	PAK4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4)	PAK4 KIAA1142	16059;	9606.ENSP00000469413;
O75628	REM1_HUMAN	reviewed	Evidence at protein level	5 out of 5	GTP-binding protein REM 1 (GTPase-regulating endothelial cell sprouting) (Rad and Gem-like GTP-binding protein 1)	REM1 GES REM	15922;	9606.ENSP00000201979;
P78504	JAG1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339)	JAG1 JAGL1	6188;	9606.ENSP00000254958;
P05121	PAI1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Plasminogen activator inhibitor 1 (PAI) (PAI-1) (Endothelial plasminogen activator inhibitor) (Serpin E1)	SERPINE1 PAI1 PLANH1	8583;	9606.ENSP00000223095;
Q16674	MIA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Melanoma-derived growth regulatory protein (Melanoma inhibitory activity protein)	MIA	7076;	9606.ENSP00000263369;
P51608	MECP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Methyl-CpG-binding protein 2 (MeCp-2 protein) (MeCp2)	MECP2	6990;	9606.ENSP00000395535;
Q9H488	OFUT1_HUMAN	reviewed	Evidence at protein level	5 out of 5	GDP-fucose protein O-fucosyltransferase 1 (EC 2.4.1.221) (Peptide-O-fucosyltransferase 1) (O-FucT-1)	POFUT1 FUT12 KIAA0180	14988;	9606.ENSP00000364902;
Q8NHC4	O10J5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Olfactory receptor 10J5 (Olfactory receptor OR1-28)	OR10J5	14993;	9606.ENSP00000334441;
Q9UPX6	MNAR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Major intrinsically disordered Notch2-binding receptor 1 (Membrane integral NOTCH2-associated receptor 1) (Ubiquitination and mTOR signaling protein)	MINAR1 KIAA1024 UBTOR	29172;	9606.ENSP00000307461;
P43121	MUC18_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cell surface glycoprotein MUC18 (Cell surface glycoprotein P1H12) (Melanoma cell adhesion molecule) (Melanoma-associated antigen A32) (Melanoma-associated antigen MUC18) (S-endo 1 endothelial-associated antigen) (CD antigen CD146)	MCAM MUC18	6934;	9606.ENSP00000264036;
P01236	PRL_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prolactin (PRL)	PRL	9445;	9606.ENSP00000302150;
P19526	FUT1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Galactoside alpha-(1,2)-fucosyltransferase 1 (Alpha(1,2)FT 1) (Blood group H alpha 2-fucosyltransferase) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1) (Type 1 galactoside alpha-(1,2)-fucosyltransferase FUT1) (EC 2.4.1.69) (Type 2 galactoside alpha-(1,2)-fucosyltransferase FUT1) (EC 2.4.1.344)	FUT1 H HSC	4012;	9606.ENSP00000312021;
P15104	GLNA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate--ammonia ligase) (Palmitoyltransferase GLUL) (EC 2.3.1.225)	GLUL GLNS	4341;	9606.ENSP00000307900;
P08581	MET_HUMAN	reviewed	Evidence at protein level	5 out of 5	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	MET	7029;	9606.ENSP00000317272;
Q01196	RUNX1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit)	RUNX1 AML1 CBFA2	10471;	9606.ENSP00000300305;
Q13950	RUNX2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Runt-related transcription factor 2 (Acute myeloid leukemia 3 protein) (Core-binding factor subunit alpha-1) (CBF-alpha-1) (Oncogene AML-3) (Osteoblast-specific transcription factor 2) (OSF-2) (Polyomavirus enhancer-binding protein 2 alpha A subunit) (PEA2-alpha A) (PEBP2-alpha A) (SL3-3 enhancer factor 1 alpha A subunit) (SL3/AKV core-binding factor alpha A subunit)	RUNX2 AML3 CBFA1 OSF2 PEBP2A	10472;	9606.ENSP00000360493;
Q9NQC3	RTN4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Reticulon-4 (Foocen) (Neurite outgrowth inhibitor) (Nogo protein) (Neuroendocrine-specific protein) (NSP) (Neuroendocrine-specific protein C homolog) (RTN-x) (Reticulon-5)	RTN4 KIAA0886 NOGO My043 SP1507	14085;	9606.ENSP00000337838;
P49591	SYSC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serine--tRNA ligase, cytoplasmic (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)	SARS1 SARS SERS	10537;	9606.ENSP00000234677;
P23381	SYWC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tryptophan--tRNA ligase, cytoplasmic (EC 6.1.1.2) (Interferon-induced protein 53) (IFP53) (Tryptophanyl-tRNA synthetase) (TrpRS) (hWRS) [Cleaved into: T1-TrpRS; T2-TrpRS]	WARS1 IFI53 WARS WRS	12729;	9606.ENSP00000347495;
Q9UGM6	SYWM_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tryptophan--tRNA ligase, mitochondrial (EC 6.1.1.2) ((Mt)TrpRS) (Tryptophanyl-tRNA synthetase) (TrpRS)	WARS2	12730;	9606.ENSP00000235521;
P61586	RHOA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transforming protein RhoA (EC 3.6.5.2) (Rho cDNA clone 12) (h12)	RHOA ARH12 ARHA RHO12	667;	9606.ENSP00000400175;
P62745	RHOB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Rho-related GTP-binding protein RhoB (Rho cDNA clone 6) (h6)	RHOB ARH6 ARHB	668;	9606.ENSP00000272233;
Q96HF1	SFRP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Secreted frizzled-related protein 2 (FRP-2) (sFRP-2) (Secreted apoptosis-related protein 1) (SARP-1)	SFRP2 FRP2 SARP1 FKSG12 UNQ361/PRO697	10777;	9606.ENSP00000274063;
Q9H6I2	SOX17_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transcription factor SOX-17	SOX17	18122;	9606.ENSP00000297316;
Q9Y3M8	STA13_HUMAN	reviewed	Evidence at protein level	5 out of 5	StAR-related lipid transfer protein 13 (46H23.2) (Deleted in liver cancer 2 protein) (DLC-2) (Rho GTPase-activating protein) (START domain-containing protein 13) (StARD13)	STARD13 DLC2 GT650	19164;	9606.ENSP00000338785;
Q15464	SHB_HUMAN	reviewed	Evidence at protein level	5 out of 5	SH2 domain-containing adapter protein B	SHB	10838;	9606.ENSP00000366936;
P42224	STAT1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Signal transducer and activator of transcription 1-alpha/beta (Transcription factor ISGF-3 components p91/p84)	STAT1	11362;	9606.ENSP00000354394;
P23297	S10A1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein S100-A1 (S-100 protein alpha chain) (S-100 protein subunit alpha) (S100 calcium-binding protein A1)	S100A1 S100A	10486;	9606.ENSP00000292169;
P27169	PON1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serum paraoxonase/arylesterase 1 (PON 1) (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (Aromatic esterase 1) (A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1)	PON1 PON	9204;	9606.ENSP00000222381;
P49768	PSN1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Presenilin-1 (PS-1) (EC 3.4.23.-) (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12 (PS1-CTF12)]	PSEN1 AD3 PS1 PSNL1	9508;	9606.ENSP00000326366;
Q9UM00	TMCO1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Calcium load-activated calcium channel (CLAC channel) (Transmembrane and coiled-coil domain-containing protein 1) (Transmembrane and coiled-coil domains protein 4) (Xenogeneic cross-immune protein PCIA3)	TMCO1 TMCC4 PNAS-10 PNAS-136 UNQ151/PRO177	18188;	9606.ENSP00000480514;
Q9NP31	SH22A_HUMAN	reviewed	Evidence at protein level	5 out of 5	SH2 domain-containing protein 2A (SH2 domain-containing adapter protein) (T cell-specific adapter protein) (TSAd) (VEGF receptor-associated protein)	SH2D2A SCAP TSAD VRAP	10821;	9606.ENSP00000376123;
Q9UPZ6	THS7A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Thrombospondin type-1 domain-containing protein 7A [Cleaved into: Thrombospondin type-1 domain-containing protein 7A, soluble form]	THSD7A KIAA0960	22207;	9606.ENSP00000406482;
Q5JRA6	TGO1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transport and Golgi organization protein 1 homolog (TANGO1) (C219-reactive peptide) (D320) (Melanoma inhibitory activity protein 3)	MIA3 KIAA0268 TANGO UNQ6077/PRO20088	24008;	9606.ENSP00000340900;
P17252	KPCA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13)	PRKCA PKCA PRKACA	9393;	9606.ENSP00000408695;
P09917	LOX5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34)	ALOX5 LOG5	435;	9606.ENSP00000363512;
Q96S42	NODAL_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nodal homolog	NODAL	7865;	9606.ENSP00000287139;
P55347	PKNX1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Homeobox protein PKNOX1 (Homeobox protein PREP-1) (PBX/knotted homeobox 1)	PKNOX1 PREP1	9022;	9606.ENSP00000291547;
O14495	PLPP3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Phospholipid phosphatase 3 (EC 3.1.3.-) (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 3) (PAP2-beta) (Phosphatidate phosphohydrolase type 2b) (Phosphatidic acid phosphatase 2b) (PAP-2b) (PAP2b) (Vascular endothelial growth factor and type I collagen-inducible protein) (VCIP)	PLPP3 LPP3 PPAP2B	9229;	9606.ENSP00000360296;
Q16647	PTGIS_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prostacyclin synthase (EC 5.3.99.4) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152) (Prostaglandin I2 synthase)	PTGIS CYP8 CYP8A1	9603;	9606.ENSP00000244043;
P17542	TAL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	T-cell acute lymphocytic leukemia protein 1 (TAL-1) (Class A basic helix-loop-helix protein 17) (bHLHa17) (Stem cell protein) (T-cell leukemia/lymphoma protein 5)	TAL1 BHLHA17 SCL TCL5	11556;	9606.ENSP00000294339;
P57105	SYJ2B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Synaptojanin-2-binding protein (Mitochondrial outer membrane protein 25)	SYNJ2BP OMP25	18955;	9606.ENSP00000256366;
P01106	MYC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Myc proto-oncogene protein (Class E basic helix-loop-helix protein 39) (bHLHe39) (Proto-oncogene c-Myc) (Transcription factor p64)	MYC BHLHE39	7553;	9606.ENSP00000479618;
Q9HDB5	NRX3B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Neurexin-3-beta (Neurexin III-beta) [Cleaved into: Neurexin-3-beta, soluble form; Neurexin-3-beta, C-terminal fragment (NRXN3-CTF)]	NRXN3 KIAA0743	8010;	
O15530	PDPK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1)	PDPK1 PDK1	8816;	9606.ENSP00000344220;
P29590	PML_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein PML (E3 SUMO-protein ligase PML) (EC 2.3.2.-) (Promyelocytic leukemia protein) (RING finger protein 71) (RING-type E3 SUMO transferase PML) (Tripartite motif-containing protein 19) (TRIM19)	PML MYL PP8675 RNF71 TRIM19	9113;	9606.ENSP00000268058;
Q05397	FAK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK)	PTK2 FAK FAK1	9611;	9606.ENSP00000341189;
Q9Y2N7	HIF3A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Hypoxia-inducible factor 3-alpha (HIF-3-alpha) (HIF3-alpha) (Basic-helix-loop-helix-PAS protein MOP7) (Class E basic helix-loop-helix protein 17) (bHLHe17) (HIF3-alpha-1) (Inhibitory PAS domain protein) (IPAS) (Member of PAS protein 7) (PAS domain-containing protein 7)	HIF3A BHLHE17 MOP7 PASD7	15825;	9606.ENSP00000366898;
Q02363	ID2_HUMAN	reviewed	Evidence at protein level	5 out of 5	DNA-binding protein inhibitor ID-2 (Class B basic helix-loop-helix protein 26) (bHLHb26) (Inhibitor of DNA binding 2) (Inhibitor of differentiation 2)	ID2 BHLHB26	5361;	9606.ENSP00000234091;
Q5UE93	PI3R6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Phosphoinositide 3-kinase regulatory subunit 6 (Phosphoinositide 3-kinase gamma adapter protein of 87 kDa) (p84 PI3K adapter protein) (p84 PIKAP) (p87 PI3K adapter protein) (p87PIKAP)	PIK3R6 C17orf38	27101;	9606.ENSP00000480157;
P37231	PPARG_HUMAN	reviewed	Evidence at protein level	5 out of 5	Peroxisome proliferator-activated receptor gamma (PPAR-gamma) (Nuclear receptor subfamily 1 group C member 3)	PPARG NR1C3	9236;	9606.ENSP00000287820;
O00141	SGK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1)	SGK1 SGK	10810;	9606.ENSP00000356832;
P05230	FGF1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Fibroblast growth factor 1 (FGF-1) (Acidic fibroblast growth factor) (aFGF) (Endothelial cell growth factor) (ECGF) (Heparin-binding growth factor 1) (HBGF-1)	FGF1 FGFA	3665;	9606.ENSP00000480791;
Q92859	NEO1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Neogenin (Immunoglobulin superfamily DCC subclass member 2)	NEO1 IGDCC2 NGN	7754;	9606.ENSP00000341198;
Q15678	PTN14_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tyrosine-protein phosphatase non-receptor type 14 (EC 3.1.3.48) (Protein-tyrosine phosphatase pez)	PTPN14 PEZ PTPD2	9647;	9606.ENSP00000355923;
Q9H3S1	SEM4A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Semaphorin-4A (Semaphorin-B) (Sema B)	SEMA4A SEMAB SEMB UNQ783/PRO1317	10729;	9606.ENSP00000357268;
Q6UX71	PXDC2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein)	PLXDC2 TEM7R UNQ2514/PRO6003	21013;	9606.ENSP00000366460;
P13521	SCG2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Secretogranin-2 (Chromogranin-C) (Secretogranin II) (SgII) [Cleaved into: Secretoneurin (SN); Manserin]	SCG2 CHGC	10575;	9606.ENSP00000304133;
P0DME0	SETLP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein SETSIP (SET pseudogene protein 18) (SET similar protein) (Similar to SET translocation protein)	SETSIP SETP18	42937;	9606.ENSP00000480946;
Q96EB6	SIR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	NAD-dependent protein deacetylase sirtuin-1 (hSIRT1) (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-1) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1) (hSIR2) [Cleaved into: SirtT1 75 kDa fragment (75SirT1)]	SIRT1 SIR2L1	14929;	9606.ENSP00000212015;
Q9H0F6	SHRPN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Sharpin (Shank-associated RH domain-interacting protein) (Shank-interacting protein-like 1) (hSIPL1)	SHARPIN SIPL1 PSEC0216	25321;	9606.ENSP00000381698;
Q8IXJ6	SIR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	NAD-dependent protein deacetylase sirtuin-2 (EC 2.3.1.286) (NAD-dependent protein defatty-acylase sirtuin-2) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2)	SIRT2 SIR2L SIR2L2	10886;	9606.ENSP00000249396;
P37173	TGFR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	TGF-beta receptor type-2 (TGFR-2) (EC 2.7.11.30) (TGF-beta type II receptor) (Transforming growth factor-beta receptor type II) (TGF-beta receptor type II) (TbetaR-II)	TGFBR2	11773;	9606.ENSP00000351905;
P26447	S10A4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein S100-A4 (Calvasculin) (Metastasin) (Placental calcium-binding protein) (Protein Mts1) (S100 calcium-binding protein A4)	S100A4 CAPL MTS1	10494;	9606.ENSP00000357705;
P21673	SAT1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Diamine acetyltransferase 1 (EC 2.3.1.57) (Polyamine N-acetyltransferase 1) (Putrescine acetyltransferase) (Spermidine/spermine N(1)-acetyltransferase 1) (SSAT) (SSAT-1)	SAT1 SAT	10540;	9606.ENSP00000368572;
P17861	XBP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	X-box-binding protein 1 (XBP-1) (Tax-responsive element-binding protein 5) (TREB-5) [Cleaved into: X-box-binding protein 1, cytoplasmic form; X-box-binding protein 1, luminal form]	XBP1 TREB5 XBP2	12801;	9606.ENSP00000216037;
P61371	ISL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Insulin gene enhancer protein ISL-1 (Islet-1)	ISL1	6132;	9606.ENSP00000230658;
P08514	ITA2B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Integrin alpha-IIb (GPalpha IIb) (GPIIb) (Platelet membrane glycoprotein IIb) (CD antigen CD41) [Cleaved into: Integrin alpha-IIb heavy chain; Integrin alpha-IIb light chain, form 1; Integrin alpha-IIb light chain, form 2]	ITGA2B GP2B ITGAB	6138;	9606.ENSP00000262407;
P42338	PK3CB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform (PI3-kinase subunit beta) (PI3K-beta) (PI3Kbeta) (PtdIns-3-kinase subunit beta) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit beta) (PtdIns-3-kinase subunit p110-beta) (p110beta) (Serine/threonine protein kinase PIK3CB) (EC 2.7.11.1)	PIK3CB PIK3C1	8976;	9606.ENSP00000289153;
P08047	SP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transcription factor Sp1	SP1 TSFP1	11205;	9606.ENSP00000329357;
Q9NVD7	PARVA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Alpha-parvin (Actopaxin) (CH-ILKBP) (Calponin-like integrin-linked kinase-binding protein) (Matrix-remodeling-associated protein 2)	PARVA MXRA2	14652;	9606.ENSP00000334008;
P00747	PLMN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Angiostatin; Plasmin heavy chain A, short form; Plasmin light chain B]	PLG	9071;	9606.ENSP00000308938;
Q8N474	SFRP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Secreted frizzled-related protein 1 (FRP-1) (sFRP-1) (Secreted apoptosis-related protein 2) (SARP-2)	SFRP1 FRP FRP1 SARP2	10776;	9606.ENSP00000220772;
Q13586	STIM1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Stromal interaction molecule 1	STIM1 GOK	11386;	
Q9NZQ3	SPN90_HUMAN	reviewed	Evidence at protein level	5 out of 5	NCK-interacting protein with SH3 domain (54 kDa VacA-interacting protein) (54 kDa vimentin-interacting protein) (VIP54) (90 kDa SH3 protein interacting with Nck) (AF3p21) (Dia-interacting protein 1) (DIP-1) (Diaphanous protein-interacting protein) (SH3 adapter protein SPIN90) (WASP-interacting SH3-domain protein) (WISH) (Wiskott-Aldrich syndrome protein-interacting protein)	NCKIPSD AF3P21 SPIN90	15486;	9606.ENSP00000294129;
P11831	SRF_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serum response factor (SRF)	SRF	11291;	9606.ENSP00000265354;
O43597	SPY2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein sprouty homolog 2 (Spry-2)	SPRY2	11270;	9606.ENSP00000366306;
Q7Z5H3	RHG22_HUMAN	reviewed	Evidence at protein level	5 out of 5	Rho GTPase-activating protein 22 (Rho-type GTPase-activating protein 22)	ARHGAP22 RHOGAP2	30320;	9606.ENSP00000412461;
Q8WZ75	ROBO4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Roundabout homolog 4 (Magic roundabout)	ROBO4 UNQ421/PRO3674	17985;	9606.ENSP00000304945;
P36897	TGFR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (Activin A receptor type II-like protein kinase of 53kD) (Activin receptor-like kinase 5) (ALK-5) (ALK5) (Serine/threonine-protein kinase receptor R4) (SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I)	TGFBR1 ALK5 SKR4	11772;	9606.ENSP00000364133;
Q15797	SMAD1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mothers against decapentaplegic homolog 1 (MAD homolog 1) (Mothers against DPP homolog 1) (JV4-1) (Mad-related protein 1) (SMAD family member 1) (SMAD 1) (Smad1) (hSMAD1) (Transforming growth factor-beta-signaling protein 1) (BSP-1)	SMAD1 BSP1 MADH1 MADR1	6767;	9606.ENSP00000426568;
Q13591	SEM5A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Semaphorin-5A (Semaphorin-F) (Sema F)	SEMA5A SEMAF	10736;	9606.ENSP00000371936;
P13385	TDGF1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Teratocarcinoma-derived growth factor 1 (Cripto-1 growth factor) (CRGF) (Epidermal growth factor-like cripto protein CR1)	TDGF1 CRIPTO	11701;	9606.ENSP00000296145;
Q09428	ABCC8_HUMAN	reviewed	Evidence at protein level	5 out of 5	ATP-binding cassette sub-family C member 8 (Sulfonylurea receptor 1)	ABCC8 HRINS SUR SUR1	59;	9606.ENSP00000303960;
P63104	1433Z_HUMAN	reviewed	Evidence at protein level	5 out of 5	14-3-3 protein zeta/delta (Protein kinase C inhibitor protein 1) (KCIP-1)	YWHAZ	12855;	9606.ENSP00000379287;
P62324	BTG1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein BTG1 (B-cell translocation gene 1 protein)	BTG1	1130;	9606.ENSP00000256015;
Q9UQB8	BAIP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Protein BAP2) (Fas ligand-associated factor 3) (FLAF3) (Insulin receptor substrate p53/p58) (IRS-58) (IRSp53/58) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53)	BAIAP2	947;	9606.ENSP00000316338;
Q05682	CALD1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Caldesmon (CDM)	CALD1 CAD CDM	1441;	9606.ENSP00000354826;
P78536	ADA17_HUMAN	reviewed	Evidence at protein level	5 out of 5	Disintegrin and metalloproteinase domain-containing protein 17 (ADAM 17) (EC 3.4.24.86) (Snake venom-like protease) (TNF-alpha convertase) (TNF-alpha-converting enzyme) (CD antigen CD156b)	ADAM17 CSVP TACE	195;	9606.ENSP00000309968;
Q9H6E4	CC134_HUMAN	reviewed	Evidence at protein level	5 out of 5	Coiled-coil domain-containing protein 134	CCDC134	26185;	9606.ENSP00000255784;
P51671	CCL11_HUMAN	reviewed	Evidence at protein level	5 out of 5	Eotaxin (C-C motif chemokine 11) (Eosinophil chemotactic protein) (Small-inducible cytokine A11)	CCL11 SCYA11	10610;	9606.ENSP00000302234;
O00501	CLD5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Claudin-5 (Transmembrane protein deleted in VCFS) (TMDVCF)	CLDN5 AWAL TMVCF	2047;	9606.ENSP00000385477;
P23946	CMA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Chymase (EC 3.4.21.39) (Alpha-chymase) (Mast cell protease I)	CMA1 CYH CYM	2097;	9606.ENSP00000250378;
Q99828	CIB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Calcium and integrin-binding protein 1 (CIB) (Calcium- and integrin-binding protein) (CIBP) (Calmyrin) (DNA-PKcs-interacting protein) (Kinase-interacting protein) (KIP) (SNK-interacting protein 2-28) (SIP2-28)	CIB1 CIB KIP PRKDCIP	16920;	
Q99788	CML1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Chemerin-like receptor 1 (Chemokine-like receptor 1) (G-protein coupled receptor ChemR23) (G-protein coupled receptor DEZ)	CMKLR1 CHEMR23 DEZ	2121;	9606.ENSP00000311733;
Q86T13	CLC14_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-type lectin domain family 14 member A (Epidermal growth factor receptor 5) (EGFR-5)	CLEC14A C14orf27 EGFR5 UNQ236/PRO269	19832;	9606.ENSP00000353013;
Q9Y271	CLTR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cysteinyl leukotriene receptor 1 (CysLTR1) (Cysteinyl leukotriene D4 receptor) (LTD4 receptor) (G-protein coupled receptor HG55) (HMTMF81)	CYSLTR1 CYSLT1	17451;	9606.ENSP00000478492;
O75829	CNMD_HUMAN	reviewed	Evidence at protein level	5 out of 5	Leukocyte cell-derived chemotaxin 1 (Chondromodulin) [Cleaved into: Chondrosurfactant protein (CH-SP); Chondromodulin-1 (Chondromodulin-I) (ChM-I)]	CNMD CHMI LECT1 MYETS1	17005;	9606.ENSP00000367198;
P48736	PK3CG_HUMAN	reviewed	Evidence at protein level	5 out of 5	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (PI3-kinase subunit gamma) (PI3K-gamma) (PI3Kgamma) (PtdIns-3-kinase subunit gamma) (EC 2.7.1.137) (EC 2.7.1.153) (EC 2.7.1.154) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma) (PtdIns-3-kinase subunit p110-gamma) (p110gamma) (Phosphoinositide-3-kinase catalytic gamma polypeptide) (Serine/threonine protein kinase PIK3CG) (EC 2.7.11.1) (p120-PI3K)	PIK3CG	8978;	9606.ENSP00000352121;
Q96EP0	RNF31_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 ubiquitin-protein ligase RNF31 (EC 2.3.2.31) (HOIL-1-interacting protein) (HOIP) (RING finger protein 31) (RING-type E3 ubiquitin transferase RNF31) (Zinc in-between-RING-finger ubiquitin-associated domain protein)	RNF31 ZIBRA	16031;	9606.ENSP00000315112;
Q12884	SEPR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prolyl endopeptidase FAP (EC 3.4.21.26) (170 kDa melanoma membrane-bound gelatinase) (Dipeptidyl peptidase FAP) (EC 3.4.14.5) (Fibroblast activation protein alpha) (FAPalpha) (Gelatine degradation protease FAP) (EC 3.4.21.-) (Integral membrane serine protease) (Post-proline cleaving enzyme) (Serine integral membrane protease) (SIMP) (Surface-expressed protease) (Seprase) [Cleaved into: Antiplasmin-cleaving enzyme FAP, soluble form (APCE) (EC 3.4.14.5) (EC 3.4.21.-) (EC 3.4.21.26)]	FAP	3590;	9606.ENSP00000188790;
Q96N96	SPT13_HUMAN	reviewed	Evidence at protein level	5 out of 5	Spermatogenesis-associated protein 13 (APC-stimulated guanine nucleotide exchange factor 2) (Asef2)	SPATA13	23222;	9606.ENSP00000398560;
P21980	TGM2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein-glutamine gamma-glutamyltransferase 2 (EC 2.3.2.13) (Erythrocyte transglutaminase) (Heart G alpha(h)) (hhG alpha(h)) (Isopeptidase TGM2) (EC 3.4.-.-) (Protein G alpha(h)) (G(h)) (Protein-glutamine deamidase TGM2) (EC 3.5.1.44) (Protein-glutamine dopaminyltransferase TGM2) (EC 2.3.1.-) (Protein-glutamine histaminyltransferase TGM2) (EC 2.3.1.-) (Protein-glutamine noradrenalinyltransferase TGM2) (EC 2.3.1.-) (Protein-glutamine serotonyltransferase TGM2) (EC 2.3.1.-) (Tissue transglutaminase) (tTG) (tTgase) (Transglutaminase C) (TG(C)) (TGC) (TGase C) (Transglutaminase H) (TGase H) (Transglutaminase II) (TGase II) (Transglutaminase-2) (TG2) (TGase-2) (hTG2)	TGM2	11778;	9606.ENSP00000355330;
P61812	TGFB2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transforming growth factor beta-2 proprotein (Cetermin) (Glioblastoma-derived T-cell suppressor factor) (G-TSF) [Cleaved into: Latency-associated peptide (LAP); Transforming growth factor beta-2 (TGF-beta-2)]	TGFB2	11768;	9606.ENSP00000355896;
Q9Y4G8	RPGF2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Rap guanine nucleotide exchange factor 2 (Cyclic nucleotide ras GEF) (CNrasGEF) (Neural RAP guanine nucleotide exchange protein) (nRap GEP) (PDZ domain-containing guanine nucleotide exchange factor 1) (PDZ-GEF1) (RA-GEF-1) (Ras/Rap1-associating GEF-1)	RAPGEF2 KIAA0313 NRAPGEP PDZGEF1	16854;	9606.ENSP00000264431;
Q9H2S6	TNMD_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tenomodulin (TeM) (hTeM) (Chondromodulin-1-like protein) (ChM1L) (hChM1L) (Chondromodulin-I-like protein) (Myodulin) (Tendin)	TNMD CHM1L UNQ771/PRO1565	17757;	9606.ENSP00000362122;
Q63HN8	RN213_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (ALK lymphoma oligomerization partner on chromosome 17) (E3 ubiquitin-lipopolysaccharide ligase RNF213) (EC 2.3.2.-) (Mysterin) (RING finger protein 213)	RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR	14539;	9606.ENSP00000464087;
P35443	TSP4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Thrombospondin-4	THBS4 TSP4	11788;	9606.ENSP00000339730;
O94827	PKHG5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Pleckstrin homology domain-containing family G member 5 (PH domain-containing family G member 5) (Guanine nucleotide exchange factor 720) (GEF720)	PLEKHG5 KIAA0720	29105;	9606.ENSP00000439625;
P01135	TGFA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protransforming growth factor alpha [Cleaved into: Transforming growth factor alpha (TGF-alpha) (EGF-like TGF) (ETGF) (TGF type 1)]	TGFA	11765;	9606.ENSP00000295400;
P56706	WNT7B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein Wnt-7b	WNT7B	12787;	9606.ENSP00000341032;
O95398	RPGF3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Rap guanine nucleotide exchange factor 3 (Exchange factor directly activated by cAMP 1) (Exchange protein directly activated by cAMP 1) (EPAC 1) (Rap1 guanine-nucleotide-exchange factor directly activated by cAMP) (cAMP-regulated guanine nucleotide exchange factor I) (cAMP-GEFI)	RAPGEF3 CGEF1 EPAC EPAC1	16629;	9606.ENSP00000395708;
P07996	TSP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Thrombospondin-1 (Glycoprotein G)	THBS1 TSP TSP1	11785;	9606.ENSP00000260356;
O15455	TLR3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Toll-like receptor 3 (CD antigen CD283)	TLR3	11849;	9606.ENSP00000296795;
P49767	VEGFC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Vascular endothelial growth factor C (VEGF-C) (Flt4 ligand) (Flt4-L) (Vascular endothelial growth factor-related protein) (VRP)	VEGFC	12682;	9606.ENSP00000480043;
Q5D1E8	ZC12A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Endoribonuclease ZC3H12A (EC 3.1.-.-) (Monocyte chemotactic protein-induced protein 1) (MCP-induced protein 1) (MCPIP-1) (Regnase-1) (Reg1) (Zinc finger CCCH domain-containing protein 12A)	ZC3H12A MCPIP MCPIP1	26259;	9606.ENSP00000362179;
Q14119	VEZF1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Vascular endothelial zinc finger 1 (Putative transcription factor DB1) (Zinc finger protein 161)	VEZF1 DB1 ZNF161	12949;	9606.ENSP00000462337;
Q96BF3	TMIG2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transmembrane and immunoglobulin domain-containing protein 2 (CD28 homolog) (Immunoglobulin and proline-rich receptor 1) (IGPR-1)	TMIGD2 CD28H IGPR1 UNQ3059/PRO9879	28324;	9606.ENSP00000301272;
P04085	PDGFA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Platelet-derived growth factor subunit A (PDGF subunit A) (PDGF-1) (Platelet-derived growth factor A chain) (Platelet-derived growth factor alpha polypeptide)	PDGFA PDGF1	8799;	9606.ENSP00000346508;
P36955	PEDF_HUMAN	reviewed	Evidence at protein level	5 out of 5	Pigment epithelium-derived factor (PEDF) (Cell proliferation-inducing gene 35 protein) (EPC-1) (Serpin F1)	SERPINF1 PEDF PIG35	8824;	9606.ENSP00000254722;
Q8IWN7	RP1L1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Retinitis pigmentosa 1-like 1 protein	RP1L1	15946;	9606.ENSP00000371923;
Q9UQP3	TENN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tenascin-N (TN-N) (Tenascin-W) (TN-W)	TNN TNW	22942;	9606.ENSP00000239462;
P49763	PLGF_HUMAN	reviewed	Evidence at protein level	5 out of 5	Placenta growth factor (PlGF)	PGF PGFL PLGF	8893;	9606.ENSP00000451040;
P35398	RORA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nuclear receptor ROR-alpha (Nuclear receptor RZR-alpha) (Nuclear receptor subfamily 1 group F member 1) (RAR-related orphan receptor A) (Retinoid-related orphan receptor-alpha)	RORA NR1F1 RZRA	10258;	9606.ENSP00000261523;
O60687	SRPX2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Sushi repeat-containing protein SRPX2 (Sushi-repeat protein upregulated in leukemia)	SRPX2 SRPUL	30668;	9606.ENSP00000362095;
P08138	TNR16_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tumor necrosis factor receptor superfamily member 16 (Gp80-LNGFR) (Low affinity neurotrophin receptor p75NTR) (Low-affinity nerve growth factor receptor) (NGF receptor) (p75 ICD) (CD antigen CD271)	NGFR TNFRSF16	7809;	9606.ENSP00000172229;
Q8N3E9	PLCD3_HUMAN	reviewed	Evidence at protein level	5 out of 5	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-3) (Phospholipase C-delta-3) (PLC-delta-3)	PLCD3 KIAA1964	9061;	9606.ENSP00000479636;
Q9H3U7	SMOC2_HUMAN	reviewed	Evidence at protein level	5 out of 5	SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2) (SMOC-2) (Smooth muscle-associated protein 2) (SMAP-2)	SMOC2 SMAP2 MSTP117	20323;	9606.ENSP00000346537;
P35590	TIE1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)	TIE1 TIE	11809;	9606.ENSP00000361554;
P40763	STAT3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Signal transducer and activator of transcription 3 (Acute-phase response factor)	STAT3 APRF	11364;	9606.ENSP00000264657;
P09486	SPRC_HUMAN	reviewed	Evidence at protein level	5 out of 5	SPARC (Basement-membrane protein 40) (BM-40) (Osteonectin) (ON) (Secreted protein acidic and rich in cysteine)	SPARC ON	11219;	9606.ENSP00000231061;
Q9H4X1	RGCC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Regulator of cell cycle RGCC (Response gene to complement 32 protein) (RGC-32)	RGCC C13orf15 RGC32	20369;	9606.ENSP00000368664;
Q9H2E6	SEM6A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Semaphorin-6A (Semaphorin VIA) (Sema VIA) (Semaphorin-6A-1) (SEMA6A-1)	SEMA6A KIAA1368 SEMAQ	10738;	9606.ENSP00000257414;
Q7Z699	SPRE1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Sprouty-related, EVH1 domain-containing protein 1 (Spred-1) (hSpred1)	SPRED1	20249;	9606.ENSP00000299084;
P31151	S10A7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein S100-A7 (Psoriasin) (S100 calcium-binding protein A7)	S100A7 PSOR1 S100A7C	10497;	9606.ENSP00000357712;
P23497	SP100_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nuclear autoantigen Sp-100 (Nuclear dot-associated Sp100 protein) (Speckled 100 kDa)	SP100	11206;	9606.ENSP00000343023;
P78362	SRPK2_HUMAN	reviewed	Evidence at protein level	5 out of 5	SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal]	SRPK2	11306;	9606.ENSP00000377262;
P35916	VGFR3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4)	FLT4 VEGFR3	3767;	9606.ENSP00000261937;
O14964	HGS_HUMAN	reviewed	Evidence at protein level	5 out of 5	Hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) (Protein pp110)	HGS HRS	4897;	9606.ENSP00000331201;
Q92626	PXDN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment]	PXDN KIAA0230 MG50 PRG2 PXD01 VPO VPO1	14966;	9606.ENSP00000252804;
P24821	TENA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)	TNC HXB	5318;	9606.ENSP00000265131;
P80108	PHLD_HUMAN	reviewed	Evidence at protein level	5 out of 5	Phosphatidylinositol-glycan-specific phospholipase D (PI-G PLD) (EC 3.1.4.50) (Glycoprotein phospholipase D) (Glycosyl-phosphatidylinositol-specific phospholipase D) (GPI-PLD) (GPI-specific phospholipase D)	GPLD1 PIGPLD1	4459;	9606.ENSP00000230036;
O14907	TX1B3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tax1-binding protein 3 (Glutaminase-interacting protein 3) (Tax interaction protein 1) (TIP-1) (Tax-interacting protein 1)	TAX1BP3 TIP1	30684;	9606.ENSP00000225525;
P04216	THY1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Thy-1 membrane glycoprotein (CDw90) (Thy-1 antigen) (CD antigen CD90)	THY1	11801;	9606.ENSP00000284240;
P21359	NF1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Neurofibromin (Neurofibromatosis-related protein NF-1) [Cleaved into: Neurofibromin truncated]	NF1	7765;	9606.ENSP00000351015;
O00329	PK3CD_HUMAN	reviewed	Evidence at protein level	5 out of 5	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (PI3-kinase subunit delta) (PI3K-delta) (PI3Kdelta) (PtdIns-3-kinase subunit delta) (EC 2.7.1.137) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit delta) (PtdIns-3-kinase subunit p110-delta) (p110delta)	PIK3CD	8977;	9606.ENSP00000366563;
P19174	PLCG1_HUMAN	reviewed	Evidence at protein level	5 out of 5	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (PLC-148) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-II) (PLC-II) (Phospholipase C-gamma-1) (PLC-gamma-1)	PLCG1 PLC1	9065;	9606.ENSP00000244007;
P13489	RINI_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ribonuclease inhibitor (Placental ribonuclease inhibitor) (Placental RNase inhibitor) (Ribonuclease/angiogenin inhibitor 1) (RAI)	RNH1 PRI RNH	10074;	9606.ENSP00000433999;
O75116	ROCK2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2)	ROCK2 KIAA0619	10252;	9606.ENSP00000317985;
Q9BXY4	RSPO3_HUMAN	reviewed	Evidence at protein level	5 out of 5	R-spondin-3 (Protein with TSP type-1 repeat) (hPWTSR) (Roof plate-specific spondin-3) (hRspo3) (Thrombospondin type-1 domain-containing protein 2)	RSPO3 PWTSR THSD2	20866;	9606.ENSP00000349131;
O94885	SASH1_HUMAN	reviewed	Evidence at protein level	5 out of 5	SAM and SH3 domain-containing protein 1 (Proline-glutamate repeat-containing protein)	SASH1 KIAA0790 PEPE1	19182;	9606.ENSP00000356437;
Q9NY15	STAB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Stabilin-1 (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 1) (FEEL-1) (MS-1 antigen)	STAB1 FEEL1 KIAA0246	18628;	9606.ENSP00000312946;
Q8WWQ8	STAB2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Stabilin-2 (FAS1 EGF-like and X-link domain-containing adhesion molecule 2) (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) (Hyaluronan receptor for endocytosis) [Cleaved into: 190 kDa form stabilin-2 (190 kDa hyaluronan receptor for endocytosis)]	STAB2 FEEL2 FELL FEX2 HARE	18629;	9606.ENSP00000373539;
Q86V25	VASH2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tubulinyl-Tyr carboxypeptidase 2 (EC 3.4.17.17) (Vasohibin-2) (Vasohibin-like protein)	VASH2 VASHL	25723;	9606.ENSP00000428324;
O94813	SLIT2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Slit homolog 2 protein (Slit-2) [Cleaved into: Slit homolog 2 protein N-product; Slit homolog 2 protein C-product]	SLIT2 SLIL3	11086;	9606.ENSP00000422591;
P41221	WNT5A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein Wnt-5a	WNT5A	12784;	9606.ENSP00000264634;
Q9Y6N7	ROBO1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1)	ROBO1 DUTT1	10249;	9606.ENSP00000420321;
P04179	SODM_HUMAN	reviewed	Evidence at protein level	5 out of 5	Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)	SOD2	11180;	9606.ENSP00000446252;
Q02763	TIE2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b)	TEK TIE2 VMCM VMCM1	11724;	9606.ENSP00000369375;
P13726	TF_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tissue factor (TF) (Coagulation factor III) (Thromboplastin) (CD antigen CD142)	F3	3541;	9606.ENSP00000334145;
O95859	TSN12_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tetraspanin-12 (Tspan-12) (Tetraspan NET-2) (Transmembrane 4 superfamily member 12)	TSPAN12 NET2 TM4SF12 UNQ774/PRO1568	21641;	9606.ENSP00000222747;
Q8IZJ1	UNC5B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Netrin receptor UNC5B (Protein unc-5 homolog 2) (Protein unc-5 homolog B) (p53-regulated receptor for death and life protein 1) (p53RDL1)	UNC5B P53RDL1 UNC5H2 UNQ1883/PRO4326	12568;	9606.ENSP00000334329;
P51817	PRKX_HUMAN	reviewed	Evidence at protein level	5 out of 5	cAMP-dependent protein kinase catalytic subunit PRKX (PrKX) (Protein kinase X) (Protein kinase X-linked) (Serine/threonine-protein kinase PRKX) (EC 2.7.11.1) (Protein kinase PKX1)	PRKX PKX1	9441;	9606.ENSP00000262848;
Q9NV29	TM100_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transmembrane protein 100	TMEM100	25607;	9606.ENSP00000465638;
P02776	PLF4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Platelet factor 4 (PF-4) (C-X-C motif chemokine 4) (Iroplact) (Oncostatin-A) [Cleaved into: Platelet factor 4, short form (Endothelial cell growth inhibitor)]	PF4 CXCL4 SCYB4	8861;	9606.ENSP00000296029;
Q9BYW2	SETD2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.359) (HIF-1) (Huntingtin yeast partner B) (Huntingtin-interacting protein 1) (HIP-1) (Huntingtin-interacting protein B) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2) (EC 2.1.1.-) (SET domain-containing protein 2) (hSET2) (p231HBP)	SETD2 HIF1 HYPB KIAA1732 KMT3A SET2 HSPC069	18420;	9606.ENSP00000386759;
Q06330	SUH_HUMAN	reviewed	Evidence at protein level	5 out of 5	Recombining binding protein suppressor of hairless (CBF-1) (J kappa-recombination signal-binding protein) (RBP-J kappa) (RBP-J) (RBP-JK) (Renal carcinoma antigen NY-REN-30)	RBPJ IGKJRB IGKJRB1 RBPJK RBPSUH	5724;	9606.ENSP00000345206;
P48023	TNFL6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tumor necrosis factor ligand superfamily member 6 (Apoptosis antigen ligand) (APTL) (CD95 ligand) (CD95-L) (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL); ADAM10-processed FasL form (APL); FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]	FASLG APT1LG1 CD95L FASL TNFSF6	11936;	9606.ENSP00000356694;
Q00604	NDP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Norrin (Norrie disease protein) (X-linked exudative vitreoretinopathy 2 protein)	NDP EVR2	7678;	9606.ENSP00000367301;
Q13464	ROCK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Rho-associated protein kinase 1 (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-35) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (p160 ROCK-1) (p160ROCK)	ROCK1	10251;	9606.ENSP00000382697;
Q9Y6W5	WASF2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Wiskott-Aldrich syndrome protein family member 2 (WASP family protein member 2) (Protein WAVE-2) (Verprolin homology domain-containing protein 2)	WASF2 WAVE2	12733;	9606.ENSP00000483313;
P49765	VEGFB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Vascular endothelial growth factor B (VEGF-B) (VEGF-related factor) (VRF)	VEGFB VRF	12681;	9606.ENSP00000311127;
Q07157	ZO1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1)	TJP1 ZO1	11827;	9606.ENSP00000281537;
Q9NZI7	UBIP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Upstream-binding protein 1 (Transcription factor LBP-1)	UBP1 LBP1	12507;	9606.ENSP00000283629;
O00755	WNT7A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein Wnt-7a	WNT7A	12786;	9606.ENSP00000285018;
Q9NP84	TNR12_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tumor necrosis factor receptor superfamily member 12A (Fibroblast growth factor-inducible immediate-early response protein 14) (FGF-inducible 14) (Tweak-receptor) (TweakR) (CD antigen CD266)	TNFRSF12A FN14	18152;	9606.ENSP00000326737;
O15041	SEM3E_HUMAN	reviewed	Evidence at protein level	5 out of 5	Semaphorin-3E	SEMA3E KIAA0331 SEMAH	10727;	9606.ENSP00000303212;
P35713	SOX18_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transcription factor SOX-18	SOX18	11194;	9606.ENSP00000341815;
Q9NYA1	SPHK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Sphingosine kinase 1 (SK 1) (SPK 1) (EC 2.7.1.91) (Acetyltransferase SPHK1) (EC 2.3.1.-)	SPHK1 SK1 SPHK SPK	11240;	9606.ENSP00000313681;
O43508	TNF12_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tumor necrosis factor ligand superfamily member 12 (APO3 ligand) (TNF-related weak inducer of apoptosis) (TWEAK) [Cleaved into: Tumor necrosis factor ligand superfamily member 12, membrane form; Tumor necrosis factor ligand superfamily member 12, secreted form]	TNFSF12 APO3L DR3LG UNQ181/PRO207	11927;	9606.ENSP00000293825;
P20333	TNR1B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tumor necrosis factor receptor superfamily member 1B (Tumor necrosis factor receptor 2) (TNF-R2) (Tumor necrosis factor receptor type II) (TNF-RII) (TNFR-II) (p75) (p80 TNF-alpha receptor) (CD antigen CD120b) (Etanercept) [Cleaved into: Tumor necrosis factor receptor superfamily member 1b, membrane form; Tumor necrosis factor-binding protein 2 (TBP-2) (TBPII)]	TNFRSF1B TNFBR TNFR2	11917;	9606.ENSP00000365435;
P35968	VGFR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor) (KDR) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309)	KDR FLK1 VEGFR2	6307;	9606.ENSP00000263923;
Q8IW00	VSTM4_HUMAN	reviewed	Evidence at protein level	5 out of 5	V-set and transmembrane domain-containing protein 4 [Cleaved into: Peptide Lv]	VSTM4 C10orf72	26470;	9606.ENSP00000331062;
Q9HCX3	ZN304_HUMAN	reviewed	Evidence at protein level	5 out of 5	Zinc finger protein 304 (KRAB-containing zinc finger protein)	ZNF304	13505;	9606.ENSP00000375586;
P21731	TA2R_HUMAN	reviewed	Evidence at protein level	5 out of 5	Thromboxane A2 receptor (TXA2-R) (Prostanoid TP receptor)	TBXA2R	11608;	9606.ENSP00000393333;
P57082	TBX4_HUMAN	reviewed	Evidence at protein level	5 out of 5	T-box transcription factor TBX4 (T-box protein 4)	TBX4	11603;	9606.ENSP00000240335;
Q8IUK5	PLDX1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Plexin domain-containing protein 1 (Tumor endothelial marker 3) (Tumor endothelial marker 7)	PLXDC1 TEM3 TEM7	20945;	9606.ENSP00000323927;
Q9NYY3	PLK2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (hPlk2) (Serine/threonine-protein kinase SNK) (hSNK) (Serum-inducible kinase)	PLK2 SNK	19699;	9606.ENSP00000274289;
O43435	TBX1_HUMAN	reviewed	Evidence at protein level	5 out of 5	T-box transcription factor TBX1 (T-box protein 1) (Testis-specific T-box protein)	TBX1	11592;	9606.ENSP00000331791;
P35442	TSP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Thrombospondin-2	THBS2 TSP2	11786;	9606.ENSP00000355751;
P52735	VAV2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanine nucleotide exchange factor VAV2 (VAV-2)	VAV2	12658;	9606.ENSP00000360916;
O43915	VEGFD_HUMAN	reviewed	Evidence at protein level	5 out of 5	Vascular endothelial growth factor D (VEGF-D) (c-Fos-induced growth factor) (FIGF)	VEGFD FIGF	3708;	9606.ENSP00000297904;
P15692	VEGFA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Vascular endothelial growth factor A (VEGF-A) (Vascular permeability factor) (VPF)	VEGFA VEGF	12680;	9606.ENSP00000478570;
Q15063	POSTN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Periostin (PN) (Osteoblast-specific factor 2) (OSF-2)	POSTN OSF2	16953;	9606.ENSP00000369071;
P10301	RRAS_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ras-related protein R-Ras (EC 3.6.5.-) (p23)	RRAS	10447;	9606.ENSP00000246792;
P17948	VGFR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT) (FLT) (Vascular permeability factor receptor)	FLT1 FLT FRT VEGFR1	3763;	9606.ENSP00000282397;
Q7L8A9	VASH1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tubulinyl-Tyr carboxypeptidase 1 (EC 3.4.17.17) (Tubulin carboxypeptidase 1) (Tyrosine carboxypeptidase 1) (TTCP 1) (Vasohibin-1)	VASH1 KIAA1036 VASH	19964;	9606.ENSP00000167106;
Q04206	TF65_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3)	RELA NFKB3	9955;	9606.ENSP00000384273;
Q9UK33	ZN580_HUMAN	reviewed	Evidence at protein level	5 out of 5	Zinc finger protein 580 (LDL-induced EC protein)	ZNF580	29473;	9606.ENSP00000443957;
Q8IWU6	SULF1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Extracellular sulfatase Sulf-1 (hSulf-1) (EC 3.1.6.-)	SULF1 KIAA1077	20391;	9606.ENSP00000260128;
Q13308	PTK7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Inactive tyrosine-protein kinase 7 (Colon carcinoma kinase 4) (CCK-4) (Protein-tyrosine kinase 7) (Pseudo tyrosine kinase receptor 7) (Tyrosine-protein kinase-like 7)	PTK7 CCK4	9618;	9606.ENSP00000418754;
Q15672	TWST1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Twist-related protein 1 (Class A basic helix-loop-helix protein 38) (bHLHa38) (H-twist)	TWIST1 BHLHA38 TWIST	12428;	9606.ENSP00000242261;
P19971	TYPH_HUMAN	reviewed	Evidence at protein level	5 out of 5	Thymidine phosphorylase (TP) (EC 2.4.2.4) (Gliostatin) (Platelet-derived endothelial cell growth factor) (PD-ECGF) (TdRPase)	TYMP ECGF1	3148;	9606.ENSP00000379038;
Q8WXD2	SCG3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Secretogranin-3 (Secretogranin III) (SgIII)	SCG3 UNQ2502/PRO5990	13707;	9606.ENSP00000220478;
P29353	SHC1_HUMAN	reviewed	Evidence at protein level	5 out of 5	SHC-transforming protein 1 (SHC-transforming protein 3) (SHC-transforming protein A) (Src homology 2 domain-containing-transforming protein C1) (SH2 domain protein C1)	SHC1 SHC SHCA	10840;	9606.ENSP00000401303;
O14746	TERT_HUMAN	reviewed	Evidence at protein level	5 out of 5	Telomerase reverse transcriptase (EC 2.7.7.49) (HEST2) (Telomerase catalytic subunit) (Telomerase-associated protein 2) (TP2)	TERT EST2 TCS1 TRT	11730;	9606.ENSP00000309572;
P57088	TMM33_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transmembrane protein 33 (Protein DB83) (SHINC-3)	TMEM33 DB83	25541;	9606.ENSP00000422473;
P01375	TNFA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]	TNF TNFA TNFSF2	11892;	9606.ENSP00000398698;
P25942	TNR5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tumor necrosis factor receptor superfamily member 5 (B-cell surface antigen CD40) (Bp50) (CD40L receptor) (CDw40) (CD antigen CD40)	CD40 TNFRSF5	11919;	9606.ENSP00000361359;
P78423	X3CL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Fractalkine (C-X3-C motif chemokine 1) (CX3C membrane-anchored chemokine) (Neurotactin) (Small-inducible cytokine D1) [Cleaved into: Processed fractalkine]	CX3CL1 FKN NTT SCYD1 A-152E5.2	10647;	9606.ENSP00000006053;
Q9UKW4	VAV3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanine nucleotide exchange factor VAV3 (VAV-3)	VAV3	12659;	9606.ENSP00000359073;
Q02108	GCYA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanylate cyclase soluble subunit alpha-1 (GCS-alpha-1) (EC 4.6.1.2) (Guanylate cyclase soluble subunit alpha-3) (GCS-alpha-3) (Soluble guanylate cyclase large subunit)	GUCY1A1 GUC1A3 GUCSA3 GUCY1A3	4685;	9606.ENSP00000296518;
P10145	IL8_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-8 (IL-8) (C-X-C motif chemokine 8) (Chemokine (C-X-C motif) ligand 8) (Emoctakin) (Granulocyte chemotactic protein 1) (GCP-1) (Monocyte-derived neutrophil chemotactic factor) (MDNCF) (Monocyte-derived neutrophil-activating peptide) (MONAP) (Neutrophil-activating protein 1) (NAP-1) (Protein 3-10C) (T-cell chemotactic factor) [Cleaved into: MDNCF-a (GCP/IL-8 protein IV) (IL8/NAP1 form I); Interleukin-8 ((Ala-IL-8)77) (GCP/IL-8 protein II) (IL-8(1-77)) (IL8/NAP1 form II) (MDNCF-b); IL-8(5-77); IL-8(6-77) ((Ser-IL-8)72) (GCP/IL-8 protein I) (IL8/NAP1 form III) (Lymphocyte-derived neutrophil-activating factor) (LYNAP) (MDNCF-c) (Neutrophil-activating factor) (NAF); IL-8(7-77) (GCP/IL-8 protein V) (IL8/NAP1 form IV); IL-8(8-77) (GCP/IL-8 protein VI) (IL8/NAP1 form V); IL-8(9-77) (GCP/IL-8 protein III) (IL8/NAP1 form VI)]	CXCL8 IL8	6025;	9606.ENSP00000306512;
Q9Y5W3	KLF2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Krueppel-like factor 2 (Lung krueppel-like factor)	KLF2 LKLF	6347;	9606.ENSP00000248071;
Q13887	KLF5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Krueppel-like factor 5 (Basic transcription element-binding protein 2) (BTE-binding protein 2) (Colon krueppel-like factor) (GC-box-binding protein 2) (Intestinal-enriched krueppel-like factor) (Transcription factor BTEB2)	KLF5 BTEB2 CKLF IKLF	6349;	9606.ENSP00000366915;
P07288	KLK3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prostate-specific antigen (PSA) (EC 3.4.21.77) (Gamma-seminoprotein) (Seminin) (Kallikrein-3) (P-30 antigen) (Semenogelase)	KLK3 APS	6364;	9606.ENSP00000314151;
Q96S16	JMJD8_HUMAN	reviewed	Evidence at protein level	5 out of 5	JmjC domain-containing protein 8 (Jumonji domain-containing protein 8)	JMJD8 C16orf20 PP14397	14148;	9606.ENSP00000399475;
Q969H8	MYDGF_HUMAN	reviewed	Evidence at protein level	5 out of 5	Myeloid-derived growth factor (MYDGF)	MYDGF C19orf10	16948;	9606.ENSP00000262947;
Q9BRK3	MXRA8_HUMAN	reviewed	Evidence at protein level	5 out of 5	Matrix remodeling-associated protein 8 (Limitrin)	MXRA8	7542;	9606.ENSP00000399229;
